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Pathogens and parasites have evolved effective strategies to gain 
access to host resources. The immune system fends off these attacks, often 
through detection of pathogen associated molecules and clearance of 
infection. This results in interactions between host and pathogen that often 
take place at molecular interfaces of immune receptors that act as a first line 
of defense to infection. Such receptors must identify pathogen-specific 
molecules and mount an appropriate response. Due to the frequency of such 
high stakes interactions between immune receptors and pathogen-derived 
molecules, the immune system is under constant evolutionary pressure to 
innovate new modes of defense and detection, while the pathogen is under 
pressure to evade these efforts and mount offensive attacks. This dynamic, 
called evolutionary conflict, is the underlying evolutionary principle inspiring 
this work. Because proteins evolve functions through DNA modifications, we 
study the effects of nucleotide variation across related species and test how 
variation affects the dynamics of protein interactions. We show that 
phylogenetic relationship is not a good indicator of functional similarity in 
the systems we tested. In the first study in Chapter III, we found that 
presence of certain amino acids in ligand-binding hotspots are more likely to 
have an effect on whether a Staphylococcus aureus inhibitor binds to immune 
receptor than overall sequence homology. In the second study that comprises 
Chapter IV, we found a similar lack of correlation between predicted 
functional outcomes and familial relationship. Similar to the study in 
v 
Chapter III, we found that certain sites could have an outsized effect on 
function that could be translated across multiple species. Interestingly, site-
level similarities at “hotspot” regions were a better indicator of function than 
phylogenetic relationships.   
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Summary of Chapters en bref 
One question that has plagued evolutionary biologists is the degree to which 
evolutionary outcomes are predictable. We know that the effects of selection, 
which act upon mutations often results in non-random phenotypes in 
populations. Some studies suggest that the degree to which randomness 
dominates evolutionary outcomes is somewhat context-specific and linked to 
the strength of selection in an environment. Elegant studies on the co- 
evolution of phasmids with the plant hosts they feed on from the Nosil lab 
suggest that the influence of the host on co-evolving species can have a 
significant impact on the phenotype of the invertebrate species which feed on 
them. This study and many similar efforts, however, do not separate the 
effects of positive from negative selection. The studies undertaken here are 
focused on the role that positive selection (the process by which beneficial 
mutations spread in a population) plays in determining phenotypes at the 
molecular level of proteins. The first chapter of this thesis establishes the 
context of our studies, which use the mammalian immune system as a model 
to study the causes and consequences of rapid evolution. Chapter III is a 
study of how nucleotide sequence diversity affects the interaction of formyl 
peptide receptors with known S. aureus inhibitor and activator proteins. 
Surprisingly we found functional differences were not always linked with the 
greatest sequence divergence. Continuing to test the influence of sequence 
diversity in paralogous primate immune receptor families, Chapter IV is 
focused on a single receptor of a five-membered family, four of which show 
high signals of positive selection. We identified a single site predicted to have 
an outsized influence on ligand interactions, a primate innovation predicted 
to improve the function of the human receptor in silico. Lastly, the greater 
contributions of research such as this are offered to the reader, along with 
some musings regarding the application of similar studies in real-world 
settings outside the laboratory.  
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Characterizing functions of beneficial mutations in primates can reveal 
function of genetic variation  
At the root of this work is a worthy question this thesis only partially 
addresses: How does genotype alter phenotype to facilitate adaptation? This 
work is a tiny part of a concerted effort by evolutionary biologists to identify 
randomly arising beneficial mutations and determine the function of such 
changes against a background that is largely noise. From a closer vantage, 
this work queries the effects of evolution through mutations. Mutations in 
DNA can affect the translation of codons, which modify the chemistry of 
proteins that may affect phenotype of the organism, thereby impacting 
fitness and the ability to propagate.  
How can we detect mutations which will have the largest effect on 
phenotypes? Lucky for us we are not starting from zero: the field has already 
devised several clever methods of detecting molecular signatures of natural 
selection that increase our chances of isolating functional changes. 
Randomness may be built into evolution through the stochasticity of the 
mechanism, but randomly accumulated mutations are then acted upon by 
competition and/or the environment.  
This work provides examples of how evolution promotes diversity of function 
through studies of immune receptors. Evolution in these systems occurs in a 
context with large influence over organismal fitness, the primate immune 
system, wherein fitness effects are often determined by the immune system’s 
ability to detect and neutralize pathogens.  
Through my work I observed a broad range of biological functions between 
species, even when genotypes are relatively similar. The differential response 
of human and bonobo FPR1 proteins (only six different codons) to bacterial 
molecules is one example of small changes resulting in relatively large effects 
on function. In another study, we saw that the Crab- eating (cynomolgous) 
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macaque CD1a receptor is predicted to perform much better at presenting 
ligands from the tuberculosis pathogen to T-cells than the human receptor, 
despite the fact that humans have a long history of association with this 
microorganism. In fact, we showed that a replacement of the amino acid in 
human with the amino acid in crab-macaque is predicted to improve antigen 
presentation by the human receptor. A key lesson from both of these studies 
is that evolution is a dynamic process, in the sense that there is no “finish 
line” or ultimate peak to climb. While biological systems may operate more 
efficiently when optimized by natural selection, the process operates in a non-
linear fashion, sampling sequence space with mixed results.  
Broader Impacts of this Work  
Pathogens rapidly evolve immune evasion mechanisms against a background 
of changing environments. Globalization and climate change have altered 
ecological niches of a wide range of species and increased the likelihood of 
new zoonotic infections due to encroachment on wildlife habitats. In fact, at 
the time of this writing, human beings are experiencing the devastating 
effects of a worldwide pandemic. The etiological agent is a beta-coronavirus 
virus called SARS-COV-2, and while its mutation rate is not remarkable 
among viruses, new variants have quickly arisen that increase transmission 
and promote antibody evasion. Hospital-associated antibiotic resistance 
among other pathogens is also on the rise, due in part to the increases in 
hospitalizations from regions unprepared for the pandemic and resultant 
strain on hospital resources sequelae to the overwhelming demand for 
supportive care. An understanding of the evolution of microbes is essential to 
preparing for the next epidemic.  
Part of an effectively tracing outbreaks in a public health crisis requires 
accurately discerning newly arising mutations of concern from those that are 
neutral, arising merely from drift. It may seem like a small facet, but it is an 
important feature of an agile public health response. Governments and 
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industry have begun to apply evolutionary theory on a wide scale in order to 
out-maneuver microbes. Work such as this can strengthen the understanding 
of mechanisms through the discovery of cryptic variation and identification of 
previously uncharacterized functions, as well as assist in practical 
approaches to decision-making by public health entities.  
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II. INTRODUCTION: RELEVANT EVOLUTIONARY CONCEPTS 
Arms Race Dynamics and Van Valen’s Red Queen Hypothesis  
In “A New Evolutionary Law'' published in 1973, Leigh Van Valen outlined 
what is now referred to as the Red Queen Hypothesis. Extinction of a species, 
he argues, is an inevitable side effect of existence that can be measured at a 
“stochastically constant” rate (Van Valen). His central argument lies in this 
seeming contradiction, how can a random process also have direction? He 
argues that within predator/prey dynamics adaptive zones exist where either 
party may have an advantage that can be subverted when a random 
mutation occurs giving one the advantage over the other: leading to an 
overall decline in fitness over time. This was against the prevailing idea that 
species evolve towards a fitness maxima at which point the evolutionary rate 
then slows (Brockhurst et al.). Evolution under Van Valen’s argument does 
not progressing towards a fitness maxima where abiotic factors are the main 
force driving evolution, but towards extinction where the main force is 
competition with other species. Within what Van Valen calls the adaptive 
zones, the rate of change is negligible, which is the basis of the Red Queen 
analogy: neither predator nor prey is makes much headway until a large 
enough change occurs to shift into the next adaptive zone. In this manner, 
like Alice and the Red Queen in Lewis Carrol’s novel, the two must maintain 
substantial speed just to maintain their original position in the fitness 
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landscape (Figure 1A). 
 
Figure 1A, 1B. The Red Queen phenomenon. The result of natural selection 
to create adaptive zones wherein one species gains fitness at the expense of 
another (Figure 1B). The co-evolving species in this scenario regain fitness 
through the same means; fixation of an allele that confers some fitness 
benefit at a cost to the other species. This metaphor for the constant 
acceleration of adaptive co-evolution resulting in negligible increase in fitness 
benefit for either species is referred to as a “molecular arms race” at the 
protein level (Daugherty and Malik; Barber and Elde; McLaughlin and 
Malik).  
Selection can be described in relationship to phenotype of the population as 
directional, stabilizing, or diversifying (Caballero). In directional selection, 
the mean fitness of the individuals shifts to the right or left of the mean, 
suggesting that an adaptive trait has moved through the population and 
shifted the phenotypic mean. Stabilizing selection occurs when extreme 
variants are not favored and so the mean phenotype is restricted to some 
central mean that is stable. Diversifying selection favors the extreme 
variants and results in bimodal distribution of phenotypes. What is common 
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to all three types of selection is the net fitness advantage at the population 
level. The mechanism by which selection has these effects on the phenotype 
of a population is through either positive or negative selection (Schultz). 
Broadly speaking, negative selection removes harmful alleles from the 
population while positive selection is the process by which beneficial alleles 
are selected for due to overall positive effects on fitness (Daugherty et al, Nei 
et al, Corona et al.). This thesis is focused on positive selection acting on the 
molecular components of life.  
Detecting Positive Selection in a Dense Mist of Neutral Mutations  
A discussion of methods for signatures indicative of positive selection in 
protein-coding sequences should be clarified. Methods differ for promoter and 
other genomic regions, and for our purposes we will just be discussing 
detection of positive selection at the codon level in protein coding alleles. 
When testing for positive selection at the gene and codon level, the null 
hypothesis usually tests whether a model fits the neutral theory of evolution 
put forward by Kimura: essentially, is this codon site or genomic region 
primarily subject to mutations conforming to random genetic drift or are 
there specific alleles or changes preferred at a site? This involves analysis of 
many sequences to set an accurate baseline for drift, which is defined by 
models as the rate of synonymous substitutions occurring at a site. The 
models detect positive or negative selection against the assumption that 
background is composed of neutral genetic drift. The random-ness of genetic 
drift, described as a “drunken walk” across sequence space expects that 
stochastically arising mutations will have one of three fates: removed if they 
are deleterious, maintained if there are neutral, and fixed in the population 
to outcompete wildtype if they are beneficial. As such when codon sites or a 
gene as a whole diverges from a random rate or evolution, it is implied that 
some form of positive or negative selection is likely to be acting on that site.  
 
8 
The neutral theory states:  
If mutants are selectively equivalent to the pre-existing forms from which 
they are derived, their fate is left to chance and their frequencies increase or 
decrease fortuitously as time goes on. (Kimura)  
Based on the assumption that neutral alleles will increase/decrease by 
chance, biologists seeking to detect sites under selection in the simplest case 
test for divergence at a codon site from randomness, where the ratio of non-
synonymous to synonymous mutations per nonsynonymous or synonymous 
site is about equal to one. Mutations that encode different amino acids from 
the original sequence are referred to as nonsynonymous substitutions, versus 
those that encode the same amino acid called synonymous mutations. This 
test assumes ample time and adequate population size for natural selection 
to act upon allele frequency. If a change at a site is beneficial under this 
model, it will appear at a rate greater than expected by chance and therefore 
increase the value of the numerator. Synonymous mutations act as a control 
for evolutionary time in a sense as well, if we assume that synonymous 
changes are effectively neutral and selection does not act on them, we also 
assume that they accumulate over time where permitted and are immune to 
the effects of phenotypic selection, although too much evolutionary time 
between sites under comparison can affect analysis through the accumulation 
of many nonsynonymous substitutions.  
This simple premise is referred to dN/dS (Ka/Ks or omega, “ω”) and has been 
employed since the method was originally described in 1980 as a way to 
compare substitution rates to a molecular clock in mRNA across different 
genes to obtain insight into sites diverging from the null hypothesis of 
neutral drift (Miyata et al.). The most widely used interface for detecting 
sites under selection was developed in 2007 by Ziheng Yang. Phylogenetic 
Analysis by Maximum Likelihood (PAML), which incorporates the logic of 
Ka/Ks into a Bayesian framework and incorporates phylogenetic information 
and branch lengths to output ranked sites which are likely to have been 
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positively selected, with an associated p- value based on chi-squared 
statistical analysis.  
 
Figure 2. Explanation of omega calculations. Non-synonymous mutations are 
nucleotide changes that result in a different amino acid produced during 
translation. Synonymous substitutions, also called silent mutations, are 
nucleotide changes that do not result in difference. A ratio greater than one of 
the number of the former types to the latter type per site is one method of 
detecting codon positions where positive selection may be occurring.  
While this method is useful to identify rare mutations that may have an 
outsized effect on phenotype, it does have its limitations. Many sites under 
selection are thought to have a subtle phenotype, and major effect mutations 
that drastically alter fitness are thought to occur rarely. These sites are, 
however, hotly pursued by scientists. Studies that identify major effect 
mutations with outsized effects are well-received because they can lead to 
promising drug targets or insight into molecular mechanisms of important 
biomolecules. Quantitative genetics reveals that since beneficial mutations 
with significant effect are so vanishingly rare in most cases (especially with 
regards to cumulative effect traits that quantitative genetics is expressly 
concerned with), even when one discovers a beneficial mutation it is most 
likely to have a minor effect on fitness as Kimura described:  
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Although a large number of mutants arise in each generation in any 
reasonably large population, the majority are lost by chance within a small 
number of generations (Fisher, 1930b; Kimura and Ohta, 1969b). It is often 
not realized that this is true not only for deleterious and selectively neutral 
mutants but also for advantageous mutants unless the advantage is very 
large. For example, if a mutant has a 1% selective advantage, the chance is 
only about 2% that it will eventually spread through the whole population 
(Haldane, 1927; Fisher, 1930b). In the remaining 98% of the cases, it will be 
lost by chance from the population without being used in evolution (Kimura).  
This begs the question, how can we find these vanishingly rare phenotypes? 
Do they exhibit molecular signatures that we can detect, or better yet can we 
use existing models to simply rank sites under selection by their predicted 
effect on biology?  
In order to approach this problem, we must first define what is missing from 
current models. Some more modern approaches to this problem have 
incorporated an intriguing binning method into detections of sites under 
selection: that of the conservative (substitutions that replace a codon with 
another of similar property, size, or other aspect) or radical (substitutions 
that replace a site with an amino acid that differs in these features). The 
larger the difference, the larger the coefficient of the radical property.  
Later, in Chapter IV I will propose that we take contextual information 
(amino-acid level biochemistry) and apply it to the original PAML framework 
(individual and population- level phylogenetics) to remove sites that are 
functionally uninteresting or minor from the analysis. Such contextual 
information may assist researchers to further parse bioinformatics data into 
sites that are likely to have a substantial effect from those that are likely to 
contribute some minor and because it is so, temporary genotype unlikely to 
fix in the population. In the meantime, I hope to explain why the immune 
system is an excellent system for studying adaptive evolution.  
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Brief Overview of Immune System Molecular Evolution  
Conceptual aspects of vertebrate immunity were put in place during the 
onset of multi- cellularity. Differentiating between self and non-self is a 
central aspect to building cooperativity in a complex organism and 
identifying invaders. Specific delineations for self- and non-self are required 
for the largescale organization of complex patterns of gene expression 
coordinated across numerous cell types to create and maintain integrity of 
intricate animals, such as primates. This foundational concept leads logically 
to the next question: what happens if non-self is detected? What systems are 
in place to protect shared resources within an organism?  
In sponges, a relatively complicated immune system has been observed and 
described as early as 1892 with the observation of phagocytic cells that engulf 
foreign bacteria (Müller and Müller; Wiens et al.). Sponges possess a Toll-like 
receptor system which acts as a rudimentary pathogen associated pattern 
receptor, four caspases, and are observed to reject allografts (Müller and 
Müller; Wiens et al.). Animals relied on innate immunity to defend from 
parasites and pathogens until innovations detected in cartilaginous fishes 
(Suckale et al.). Innate approaches to immunity are effective, and subsequent 
innovations such as the complement system, Leucine rich repeat receptors, 
Nod like-receptors and others were adaptive inclusions to the innate immune 
response over time (Suckale et al).  
Early adaptive immune receptor variable lymphocyte receptor (VLR) genes 
include some elements of innate immune receptor structure such as leucine 
rich repeats (LRR) receptors. A mature VLR requires combinatorial 
processing that results in a wide array of possible VLR sequences, which is 
thought to be the beginnings of how variability was first generated in the 
ancient immune system (Deng et al.).  
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The adaptive immune system is thought to have evolved as a unit in jawed 
fishes, since the most ancestral version of this adaptive unit was observed to 
have emerged altogether in the nurse shark: complete with proto-versions of 
RAG-genes, T-cell receptor and major histocompatibility complex (Flajnik 
and Kasahara). This system evolved in complexity, eventually gaining the 
ability to generate the large amount of sequence diversity necessary for 
mammalian B-cells to create highly specific antibodies tailored to an 
infection, a process referred to as somatic hypermutation (Di Noia and 
Neuberger).  
The immune system in vertebrates has evolved massive complexity from the 
basis of a self/non-self recognition framework. The two branches of the 
immune system, innate and adaptive, both use receptors called pattern 
recognition receptors to identify invaders, but respond differently to 
activation by foreign molecules. Broadly speaking, the innate immune 
response relies on immediate and generalized methods to eliminate 
pathogens, while the adaptive immune response relies on the generation of 
highly specific antibodies for pathogen neutralization (Cooper and Alder; 
Rosenstiel et al.; Kasahara and Flajnik; Deng et al.).  
An interesting feature of many immune-system related genes is their 
presence as large paralogous gene clusters. Many of the pattern recognition 
receptors, such as major histo- compatibility complex (MHC), the related CD1 
molecules which display lipids instead of peptides, formyl peptide receptors 
(FPRs) which bind bacterial peptides and other metabolites, Toll-Like 
receptors (TLR) which identify viruses, bacteria and other ligands are just a 
few examples of well-known PRRs that evolved distinct ligand binding 
profiles through gene duplication and neo-functionalization (Cooper and 
Alder). Interestingly, this process is on-going and copy number and ligand 
binding profiles diverge widely across related species (Yang and Shi; Levin 
and Malik; Dietschi et al.; Hughes and Piontkivska; Flajnik and Kasahara).  
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How Selection Acts on Duplicated Gene Families  
Susumu Ohno is credited with first describing the idea of highly similar 
genes resulting from duplication of existing genes. These genes are 
subsequently subject to neutral drift and subsequent selection based on the 
qualities of the stochastic mutations that arise therefrom (Ohno). The 
immune system has a plethora of gene families thought to have arisen 
through some version of this process. Some well-studied examples are the 
TLRs, the Nod-like receptors, the CEACAM proteins, FPRs, MHC, CD1 
receptors (Adrian et al.; Rosenstiel et al.; Muto et al.; Sutton et al.; Zajonc). 
Many of the receptors of the immune system evolved as paralogs after 
sequential rounds of duplication, drift, and neofunctionalization events.  
It is thought that because the first effect of gene duplication results in more 
copies of the gene, and as a result, often more of that gene product, the first 
effect of gene duplication is simply higher copy number of the original gene 
(Dittmar and Liberles). In fact this phase of the evolutionary trajectory of the 
duplicated gene is thought to be accelerated, and strangely, is thought to 
affect only one copy, which is determined by chance (Pegueroles et al.). The 
subsequent fates of a gene after duplication may be as follows: if there is 
some fitness advantage to having more of the molecule encoded by the gene, 
then evolutionary pressure may exist to maintain the original as well as the 
duplicated gene without altering the sequence substantially. In this case, the 
genes will be subject primarily to purifying selection and neutral drift. In the 
case of genes where increased dosage affects fitness negatively or is lethal, 
the gene is falls into a fitness valley and one of the genes will likely be 
silenced as a result of purifying natural selection, with the surviving gene 
finding itself in a new fitness landscape after loss of the other allele (Teufel et 
al.). If however, the duplicated gene has an effectively neutral effect on 
fitness due to dosage imbalance, the gene may first undergo drift, followed by 
natural selection acting to either increase diversity through 
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neofunctionalization when the mutations result in benefit (positive selection). 
If mutations resulting from drift have a negative effect on fitness the gene 
may be pseudogenized and silenced through purifying natural selection 
(Teufel et al.; Reams and Roth).  
Bridge.to Chapter III 
Of the gene families in the immune system which owe their origin to such an 
evolutionary history, the two families focused on in this thesis are the formyl 
peptide receptors (FPRs) and the CD1 family of receptors which will be 
discussed in detail presently. Firstly, a study of the how sequence diversity 
affects functional interactions with S. aureus inhibitor and activator across 
several related formyl peptide receptor proteins shows us how sequence 
divergence is likely not the main driver of recognition.  
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CHAPTER III: DETERMINING FUNCTIONAL DIVERSITY FROM 
SEQUENCE DIVERSITY 
Nicole Paterson and Matthew Barber conceptualized the study and the 
experimental design. Joseph Rangona and Brian Geisbrecht contributed 
reagents. Juan Tirado performed the PAML analysis for FPR2 in carnivores. 
Nicole Paterson generated the figures and performed all other experiments 
and analysis. Hussein Al-Zubieri assisted with cloning and experimental 
design. Nicole Paterson and Matt Barber wrote and edited the manuscript.  
(Formatted for submission to Journal of Molecular Biology and Evolution, 
under review).  
Dynamic evolution of bacterial ligand recognition by formyl peptide 
receptors  
Nicole M. Paterson1, Hussein Al-Zubieri1, Joseph Ragona2, Juan Tirado1, 
Brian V. Geisbrecht2, Matthew F. Barber1  
1University of Oregon Institute of Ecology and Evolution, 2Kansas State 
University Department of Biochemistry and Molecular Biophysics  
Intoduction  
The formyl peptide receptors (FPRs) are a family of G-protein coupled 
receptors (GPCRs) that play crucial roles in the recruitment and activation of 
leukocytes. Early studies demonstrated that human cell lines migrate 
towards N-formylated peptides, which are present in bacterial and 
mitochondrial, but not eukaryotic, proteins (Schiffmann et al.). These 
findings led to the discovery of FPRs as a new class of pattern recognition 
receptor with the ability to discriminate between ‘self’ and ‘non-self’ 
molecules in order to activate downstream immune responses (Pike et al.; 
Zigmond). Since then, additional microbial and host-derived ligands have 
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been identified for specific FPR homologs. Of the three FPRs in humans, each 
has been shown to possess a unique ligand-binding profile (Karlsson et al.; 
Schepetkin et al.; Kretschmer et al.), with a range of outputs in response to 
ligand. For example, recognition of lipoxin-A by FPR2 leads to the 
suppression of inflammatory signaling, whereas binding of bacterial-specific 
formylated peptides by FPR1 results in induction of the inflammatory 
response and cell chemotaxis towards ligand source (John et al.; Le et al.; 
Schepetkin et al.).  
Neutrophils and other myeloid cells play a central role in innate pathogen 
recognition and express high levels of FPRs in humans. When neutrophils 
detect foreign molecules via FPR activation, the cell migrates towards the 
source of the signal. Upon reaching an infection site, neutrophils contribute 
to pathogen clearance through phagocytosis, release of toxic granule 
molecules, and a rapid oxidative burst which produces high levels of 
antimicrobial reactive oxygen species and reactive nitrogen species (Shimizu 
et al.; Önnheim et al.; Bufe et al.). Neutrophils constitute roughly 50% of 
circulating leukocytes and are capable of detecting nanomolar concentrations 
of pathogen-derived peptides through activation of FPR1 and FPR2 (Fu et al.; 
Le et al.). Natural killer cells, monocytes, and macrophages also express high 
levels of formyl peptide receptors which similarly contribute to cell activation 
and chemotaxis (Leslie et al.; Kim et al.; Crouser et al.).  
Previous studies have detected signals of positive selection in FPRs 1 and 2 in 
the mammalian lineage through observation of high dN/dS ratios at several 
codon sites (Muto et al.). This is consistent with a model of formyl peptide 
receptors undergoing positive selection at sites important for immune 
function, most likely pathogen detection. All three FPR genes are located on 
chromosome 19 in humans (Bao et al.) and orthologous FPR gene regions in 
primates have previously demonstrated evidence of accelerated evolution in 
promoter and other regions (Yang et al.) as well as heightened occurrences of 
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single nucleotide polymorphisms (Harris et al.). Many other immune system 
related proteins including Toll-like receptors (TLRs), TRIM5, major 
histocompatibility complex (MHC) family genes, and transferrin, have been 
subject to repeated positive selection during mammalian evolution (Brunette 
et al.; McLaughlin and Malik; Daugherty and Malik; Barber and Elde; Aleru 
and Barber; Paterson et al.; Sawyer et al.; van der Lee et al.; Hughes and 
Piontkivska; Hughes and Nei). Taken together, the central role of FPRs in 
innate immune function coupled with previously identified signatures of 
positive selection suggest there may be important functional consequences for 
sequence-level variation observed in this family of receptors.  
Results  
Gene Loss and Rapid Evolution of FPRs in Primates and Carnivores  
We found substantial evidence that FPR1 in several primate species is 
contracting (Yang and Shi) as demonstrated by a lack of FPR1 detectable 
expression in New World monkey whole blood, brain, lung and other RNA-
Seq data from AceView (Thierry-Mieg and Thierry- Mieg) (Figure 1A). 
Previous reports looking at FPR expression in the primate vomeronasal 
organ identified FPR1 pseudogene in marmosets (Yang and Shi). We 
identified several additional pseudogenes in other New World Monkey 
lineages, after observing absence of gene expression as a lack of annotated or 
homologous FPR1 New World monkey genes in the NCBI database. The 
absence of FPR1 expression suggested to us that there may be additional 
pseudogenes in other New World Monkeys. We scanned available New World 
monkey genomes using BLAT search, and found additional regions of 
homology to FPR1 genes that when tested for the presence of exons using 
MIT’s GENESCAN tool (Burge) failed to identify exons at the given 
probability cut-off. We aligned pseudogenes identified to human FPR1 and 
marmoset FPR1 pseudogene, which are available as high coverage, well-
annotated genes in the NCBI database. In Sapajus apella, Cebus imitator, 
18 
Saimiri boliviensis and Aotus nancymaae at the genomic loci with substantial 
homology to FPR1 (located to the plus-strand adjacent to the FPR2 and FPR3 
genes on chromosome 19) these gene regions contain homology but lack one 
or more features of a functional gene (Figure 2A, Figure 2B). Saimiri 
boliviensis pseudogene is the most striking, as this region has the least 
homology (77.5% identity in 271bp region located on the plus-strand adjacent 
to the FPR2 and FPR3 genes on chromosome 19) that lacks evidence of a 
start or stop codon and lacks significant homology to marmoset FPR1 outside 
the 271bp region. A caveat to this analysis is that each of these genomes has 
different levels of coverage and/or one or more builds (details on the quality of 
genomes used in this study can be found in the Supplemental Figure 2). 
However, Saimiri boliviensis, Aotus nancymaae and Callithrix jacchus have 
multiple builds with high coverage (Saimiri boliviensis: 2 builds most recent 
111x coverage, Aotus nancymaae: 4 builds, most recent 132x, Callithrix 
jacchus: 11 builds, most recent 40x coverage ) and good agreement with 
regards to pseudogenes at these regions across builds (full details in 
Supplemental Figure 2).  
The gene expression and genome scanning analysis suggest that FPR1 
function was lost early in the New World monkey lineage. This suggests there 
may be some diversification along the branch leading to FPR2 in New World 
monkeys. Because New World monkeys also appear to down-regulate 
expression of FPR3 (although the gene is still intact in the genomes of all 
New World primates scanned), there appears to be some downregulation of 
gene expression in FPR3 which is notable. Like other immune receptor 
families including TLRs (Levin and Malik), gene duplication and loss have 
occurred periodically throughout the evolution of the FPR gene family in 
mammals as evidenced by the variable copy number across different 
mammalian lineages (Figure 1B), and a loss of FPR gene expression is not an 
unusual event in mammals.  
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The differential gene expression profile in New World monkeys that shows 
increased expression of FPR2 and decreased expression of FPR1 and FPR3 is 
supported by our analysis of positive selection at the codon level in primate 
genes. Our analysis shows good agreement with previous studied in 
mammals showing heightened rates of positive selection in FPR1 and FPR2 
(Figure 3). We ran additional analysis testing for branch-site episodic positive 
selection using DataMonkey’s abSREL test (Smith et al.) and found evidence 
of heightened selection on the branch of the phylogenetic tree leading to the 
New World monkeys FPR2. It is possible that FPR2 has a divergent function 
from FPR2 in other primate lineages.  
Another lineage known to rely on FPR2 function solely, is the Carnivora 
clade, which encode only the single FPR2 paralog. Phylogenetic analysis of 
positive selection at the codon level in carnivores revealed similar patterns of 
positive selection in FPR2, though with one fewer site overall. The sites that 
appeared in carnivores mapped to the N terminus and the third and fourth 
extracellular domain, the exact regions that appear to be undergoing 
selection in primates as well. Curious to find out whether this lineage could 
give us insight into the evolutionary processes at play in FPR2 in mammals 
more broadly, we undertook a functional analysis using a microbial system 
likely to have interacted with most, if not all of the species we analyzed.  
Aceview NIHTPR RNA seq data plotted to display expression levels across 
primate kingdoms for hominoid (human, chimpanzee), Old World monkey 
(pig-tailed macaque, crab- eating macaque, baboon, mangabey) and New 
World monkeys (marmoset, squirrel monkey and owl monkey). High 
expression of FPR1 in hominoids of FPR1 in Whole Blood, Brain and Lung. 
Moderate-high expression in Old World monkeys and notable absence of 
FPR1 and FPR3 expression in New World monkeys. FPR2 expression is less 
extreme, but variable across kingdoms. A) Whole blood B) Brain C) Lung.  
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Figure 3. FPR1 gene expression among simian primates  
Figure 4. FPR1 pseudogenization in New World monkeys  
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Genome scanning for regions of homology using marmoset FPR1 as the query 
sequence showed evidence for loss of FPR1 functional sequence in the New 
World Monkey lineage. A) Saimiri boliviensis displayed the most significant 
gene loss at this region, with a short 271bp region with significant homology 
and no apparent start or stop codons. B) The loci where apparent 
pseudogenes were identified is relatively conserved across the New World 
monkey lineages  
 
Recognition of bacterial ligands by mammalian FPRs  
To assess the functional consequences of sequence variation in primate FPRs, 
we focused on Staphylococcus aureus interactions due to expression of both 
pathogenesis-associated inhibitors and activators shown to interact with 
FPRs (Annette M. Stemerding et al.; Sundqvist et al.; Prat et al.; Koymans et 
al.; Kretschmer et al.; Li et al.). S. aureus is a gram-positive bacterium is 
known for its multiplicity of virulence factors and rapid acquisition of 
antibiotic resistance across a broad mammalian host range including 
livestock, rodents and companion animals (Thammavongsa et al.; Koymans 
et al.; Haag et al.). This adaptable microbe colonizes the nares of roughly 30% 
of humans, but is also a major cause of skin and soft tissue infections, 
bacterial sepsis, pneumonia, and other life- threatening infections 
(Thammavongsa et al.; Haag et al.). S. aureus produces many extremely 
effective toxins that contribute to its virulence, including enteroxins, 
leukocidins, and alpha-hemolysin to name a few (Balasubramanian et al.; 
Lowy; Priatkin and Kuz’menko). S. aureus also produces a range of proteins 
that target and silence immune receptors such as TLRs, FPRs and 
complement receptors which are responsible for detecting and/or mounting an 
immune response against infection (Thammavongsa et al.; Prat et al.; 
Kretschmer et al.; Koymans et al.; Wright et al.) While S. aureus is generally 
believed to be human-adapted, primates, rodents and livestock are frequently 
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colonized by divergent strains of S. aureus and related staphylococci 
(Schaumburg et al.). Strains sampled from wild gorilla, chimpanzee, green 
monkey, and colobus contain the gene for the virulence factor staphylococcal 
enterotoxin B (SEB) as well as other virulence factors (Schaumburg et al.).  
SEB has been shown to potently activate FPRs (Dürr et al.) Kretschmer et 
al.; Fu et al., Dürr et al.). In addition, S. aureus produces formylated peptides 
that can induce cell migration in neutrophils (Dürr et al.). These bacteria also 
produce a number of inhibitory molecules that target FPRs, such as FLIPR 
and FLIPR-like which have demonstrated specificity for FPR2, although 
FLIPR-like can bind FPR1 with lower affinity (Annette M. Stemerding et al.).  
Figure 5 A,B. Evidence of repeated positive selection among primate FPRs 
A) Sites in primate FPR1 with elevated dN/dS as determined by PAML and 
HyPhy. Residues of the transmembrane domain are denoted in yellow on the 
protein diagram, with the majority of high dN/dS sites located in the 
extracellular ligand-binding loops. B) Sites in primate FPR2 with elevated 
dN/dS as determined by PAML and HyPhy. Residues of the transmembrane 
domain are denoted in yellow on the protein diagram, with all high dN/dS 
sites located in the extracellular ligand-binding loops. Branch tests indicate 
elevated dN/dS in the common ancestor of New World monkeys, which have 
also lost FPR1.  
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Figure 6. Evidence of repeated positive selection in carnivore FPR2  
 
Sites in carnivore FPR2 with elevated dN/dS as determined by PAML and 
HyPhy.  
Using HEK293T cell lines stably expressing FPR orthologs at approximately 
equivalent levels, we tested binding of FITC-labeled SEB and FLIPR-like 
proteins by flow cytometry. Most of the receptors we tested displayed some 
level of SEB binding, but surprisingly the level seen in bonobo FPR1 matched 
the binding profile of human FPR2 more than human FPR1. This was also 
true for FITC-labeled FliprLike protein. (Figure 4). This was unexpected 
given the human FPR1 receptor has very high sequence conservation with 
bonobo FPR1, diverging only at six amino acid positions overall, and far less 
sequence homology with human FPR2. Since bonobo FPR1 displayed activity 
more similar to human FPR2 in response to FLIPR-like binding as well, this 
suggests that there may be some site- specific properties that confer function 
between bonobo FPR1 and human FPR1 that are similar between bonobo and 
human FPR2.  
We next considered which amino acids were the most likely to be responsible 
for these binding differences. Without previously published crystal structures 
for FPRs, we generated homology models using I-TASSER, an online 
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webserver that uses a threading algorithm to match primary sequence data 
to crystal structures in the server’s database  (there are many related GPCRs 
with sufficient homology to act as reference crystal structures). These 
structures were docked to the entire extracellular region using the seven 
amino acids that form the region of Flipr and FliprLike N-terminal peptide 
required for its inhibitory activity (FFSYEWK)(Annette M. Stemerding et al.) 
using the Schrodinger Glide molecular modeling system. The results were 
surprising.  
Several amino acids in the first and last extracellular loops of FPR1 formed 
hydrogen bonds with the FliprLike peptide. One of these, site 190, is 
predicted to be under selection in primates (Figure 8C). Adjacent to this site 
in human FPR2, site 189 also forms a hydrogen bond to FFSYEWK in 
docking studies. Interestingly, there were several sites of overlap between the 
two including positions S6, N10, and R190 (Figure 8C). Several studies have 
shown site 190 can modify peptide binding to other microbial ligands, notably 
studies in the S. aureus chemotaxis inhibitor CHIPs, which shows a 
preference for lysine over tryptophan at position 190 (Mills et al). This same 
site has been shown to modify susceptibility of immune cells to recognition by 
the Yersinia pestis type 3 secretion system, where tryptophan at position 190 
has been shown to drastically reduce cell entry versus wildtype K190 (Osei-
Owusu et al.).  
However, in the bonobo FPR1 docking study, the region near sites 189-190 
did not interact with the FFSYEWK peptide (Figure 8B). Interestingly, it 
appears that the amino acid at position 170, which differs between human 
FPR1 and bonobo FPR1 possesses a methionine instead of a threonine at that 
position, which creates a ridge where the FFSYEWK peptide docks in the 
bonobo model. To test how this may affect the inhibitory activity of FliprLike, 
we performed an additional docking to f-MLF, the canonical activator of 
FPRs. From comparison of the docking poses of human FPR1 and bonobo 
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FPR1 we saw similar binding of the Fliprlike peptide across several of the 
extracellular loops of human FPR2 and bonobo FPR1, with the fMLF peptide 
buried in the central region of the helices (Figure 8A,B). 
Additionally we observed several naturally occurring single nucleotide 
polymorphisms in the human population R190W, predicted to be involved in 
binding Nterm FliprLike and N192K which differs between human FPR1 and 
bonobo FPR1. Additionally, the site which forms the ridge in bonobo FPR1 
T170M naturally occurs in the human population, as well as an additional 
T170P which occurs at that site as well, although at low frequency (Figure 9). 
 
 
Figure 7. Recognition of S. aureus ligands by mammalian FPRs. A,B) Data 
from at least three flow cytometry experiments for each species. Singlet cells 
were gated and percent of FL2 (488+) positive cells reported from the parent. 
C) Percent FITC+ cells plotted from a subset of singlets, HEK293T cells 
incubated with FITC-labeled protein used as control to set negative levels.  
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Figure 8. Sites that differ between human and bonobo FPR1 are adjacent to 
sites under selection in primates. A) Schrödinger Glide ligand docking 
prediction to the Nterm region of FliprLike, FFSYEWK-shown to be required 
for inhibitory function, docks in the region above the canonical FPR ligand 
fMLF. Site 190 labeled for orientation purposes. Side view shows the 
FFSYEWK docking pose internal to the alpha-helices of FPR2, aligned to the 
fMLF docking pose. B) FFSYEWK shows different hydrogen bonding patterns 
to bonobo FPR1 and docks in a slightly different region of the receptor, due to 
a protruding ridge formed by M170 in the homology model of bonobo FPR1. 
Side view of bonobo FPR1 shows similar arrangement between FFSYEWK 
and fMLF docks, despite different docking pose. C) Sites that differ between 
Bonobo FPR1 and human FPR1 are also adjacent to sites predicted to be 
undergoing positive selection. Sites labeled with red text form hydrogen 
bonds with FFSYEWK. Arrows in blue indicate sites with high dN/dS for 
FPR1, green for FPR2. Sites that diverge between Bonobo FPR1 and Human 
FPR1 in yellow. Site 192 and site 195 differ between human FPR1 and 
bonobo FPR1, but are the same for bonobo FPR1 and human FPR2. Sites that 
differ between human FPR1 and bonobo FPR1 shown at right.  
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Figure 9. Single nucleotide polymorphisms in human FPR1 at sites predicted 
to affect binding affinity to FliprLike are relatively infrequent for the 
mutation found in bonobo FPR1 that forms a new hydrogen bonding 
interaction in docking studies. Mutations at site 190 that may interfere with 
binding to FliprLike are relatively frequent.  
 
Discussion  
Studies in rodents have shown remarkable functional plasticity in FPRs 
(Dietschi et al.). This plasticity likely explains in part why these genes have 
expanded independently in so many lineages. There appears to be a broad 
capacity for FPRs to act as environmental sensors, as evinced by 
aforementioned studies in rodents. The sensitivity of detection possible for 
FPR1 which can detect formylated peptide at remarkable low nanomolar 
concentrations (Mills et al) may explain why FPR1 is so highly expressed in 
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humans even though it is associated with inflammatory disease and cancer (T 
et al.; Khau et al.; Vacchelli et al.). Since much is known about why FPR 
genes may expand in lineages, it may be worthwhile in this stage of FPR 
research to seek answers for why genes in this family may contract, such as 
observed in this study. There have been studies in humans associating FPRs 
with exacerbating human disease states such as glioblastoma (Yao et al.; 
Cussell et al.) and breast cancer (Khau et al.), especially for FPR1 which is 
strongly associated with inflammation. Additionally, FPR1 has been shown to 
be required for Yersinia pestis recognition of host cells, a function which can 
be lost when site 190 (two amino acids upstream from site 192 shown to be 
relevant in this study) is modified from an arginine to a tryptophan (Osei-
Owusu et al.). Loss of this gene may confer benefit in animals prone to 
plague, and such a scenario offers a ready explanation for why loss of a 
functionally important gene may be worth the sacrifice to the long-term 
survival of a species.  
In our system, we see many components of a classical molecular arms race 
dynamic. Evolutionary conflict is defined by multiple rounds of evasion and 
attack on resources by a pathogen on its host species, and we see elements of 
these dynamics in this system where we probed the binding profiles of an 
inhibitor and an activator across several species with evidence of beneficial 
adaptation at specific codon sites. We discovered a region in the FPRs at sites 
190/192, which may be responsible for the differences in binding that we see 
in this study. S. aureus FPR inhibitors CHIPs and Flipr/FliprLike 
preferentially bind to FPR1- R190, given that CHIPs has been shown to be 
specific for FPR1, while Flipr/FliprLike bind FPR2 with high affinity and 
FPR1 with low affinity. Given this knowledge it may be significant that 
human FPR2 encodes a charged amino acid glutamate at position 190, 
possibly reducing its affinity for CHIPs and increasing affinity for Fliprs. It is 
also possible that this region is targeted by S. aureus inhibitors due to its 
important role in ligand binding.  
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Putting together data gathered on primate FPRs in response to Staph 
activator SEB and inhibitor, FliprLike, it is noteworthy that bonobo FPR1 
bound the S. aureus inhibitor FliprLike more similarly to human FPR2 than 
human FPR1, even though it shares far more sequence similarity with 
human FPR1. It is quite possible that positive selection in carnivore FPR2 
has resulted in divergent functional response to ligand.  
Notably, this is not the first time that this region has been implicated in 
interactions with the host-microbe interface with S. aureus. A study testing 
the function of various high- prevalence SNPs in human FPRs showed 10 fold 
difference in binding for R190/K192, R190/N192 chemotaxis inhibitor of 
FPR1 (CHIPs) not seen for FPR1 W190/N192 (Mills). The relatively low 
frequency of the M170 mutation in FPR1 may be adaptive, if that site does 
indeed increase the binding affinity of FliprLike for FPR1. Given the 
relatively few sites that differ between human and bonobo, and the difference 
in size between methionine and threonine, this substation is likely to have an 
effect, supporting this possibility. The implications of this research are dual-
pronged: such studies increase our knowledge of how a genotype may affect 
susceptibility to disease, and suggest that inhibitors of inhibitors may be 
effective treatments for bacterial infection in those individuals with 
heightened susceptibility.  
Methods 
Identifying Sites of positive selection in FPRs 
We inferred amino acid sites exhibiting elevated dN/dS using multiple 
computational methods. Our dataset included all available nucleotide coding 
sequences (cDNA) for 18 primate species of FPR1 (human, drill, mangabey, 
red colobus, snub-nosed monkey, golden snub-nosed monkey, Sumatran 
orangutan, Bornean orangutan, gorilla, chimpanzee, bonobo, white-cheeked 
gibbon, green monkey, crab-eating macaque, pig-tailed macaque, gelada, olive 
baboon), with areas of ambiguity and stop codons removed. A gene tree for 
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FPR paralogs was generated with PhyML (phylogenetics by maximum 
likelihood) with 1000 bootstraps (Supplemental Figure 1)13. Potential sites 
under positive selection were detected using the phylogenetic analysis by 
maximum likelihood (PAML) package (Yang) which detects signs of positive 
selection from the frequency of nonsynonymous/synonymous amino acid 
substitutions at each site (ω = dN/dS) based on maximum likelihood. 
Additional computational methods MEME (Pond and Frost) and FuBar 
(Murrell et al.)from the DataMonkey adaptive evolution server were cross-
referenced and sites that appeared in more than one analysis with high 
confidence (p< 0.01) were included. absREL analysis which tests for branch 
site episodic selection was also performed (Smith et al.).  
Cloning and Lentiviral transduction of FPRs in HEK293T cells  
FPR1 genes for human, bonobo, gelada, and red colobus and FPR2 genes for 
human, capuchin, dog and cat were cloned from cDNA (Human FPR1 and 
FPR2) synthesized by Genewiz (gelada and red colobus) or synthesized as 
gBlocks by IDT (capuchin, dog, cat) including Kozak sequence and C-terminal 
Flag-tag and subsequently cloned into pBABE lentiviral vector using SLIC or 
Gibson cloning methods. Full length FPR1 orthologs were cloned into pBABE 
vector using the Gibson method for a FLAG epitope tag (Gibson et al., 2009). 
After expression was verified in cell lines by Western blot using anti Flag tag 
antibodies (Monoclonal ANTI-FLAG® M1, Sigma Aldrich #F3040), surface 
expression was verified for FPR1 using Thermo Fisher FPR1 polyclonal 
antibody ref number PA5-33534) and cell lines with similar percent 
expression on the cell surface were used in binding experiments. FITC-
labeling was performed per manufacturer’s instructions, and the Thermo 
ScientificTM PierceTM Dye Removal Columns, 22858 were used to remove 
excess dye per manufacturer’s instructions. A titration was performed, and 
4μg of FITC-labeled FliprLike or SEB proteins were incubated in 100μl 
sterile phosphate buffered saline + 100nM PMSF at 4°C with nutation for 1 
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hour, washed 3 with 1 ml ice-cold PBS and analyzed on a SONY SH800 flow 
cytometer.  
FliprLike Peptide Docking to human FPRs  
All structures used for analysis were generated using I-TASSER homology 
modeling server (Yang and Zhang), except for formyl-MLF and FFSYEWK, 
which represents the first six amino acids of Flipr and Flipr-Like proteins 
(Annette M. Stemerding et al.) generated in PyMol (Schrodinger). Peptide 
docking was run with Schrödinger Glide, SP and XP dock with sidechain 
protonation set to represent charged states at pH 7, highest ranking docking 
was used for analysis.  
Genome scanning for FPR1 pseudogenes in New World Monkeys  
Complete genomes for available New World Monkey species were queried for 
FPR1 pseudogenes by BLAST search, BLAT search of genome in UCSC 
Genome Browser (Callithrix jacchus, Saimiri boliviensis) while pseudogenes 
for Cebus capucinus imitator, Sapajus apella, and Aotus nancymaae were 
identified by BLAT search for homology in genome viewer in NCBI’s Genome 
Data viewer. Details for genome assemblies in Supplemental Figure 2. 
Pseudogenes were aligned using MUSCLE. Resulting data was analyzed by 
alignment and exons were searched for and in some cases eliminated using 
GENESCAN (Burge and Karlin).  
Yersinia pestis interactions with formyl peptide receptors 
Yersinia pestis, etiological agent of the Black Plague evokes dread like no 
other. Yet this deadly pathogen can be rendered relatively benign if the 
receptor required for immune cell entry, formyl peptide receptor 1 (FPR1), is 
mutated at a single amino acid position, a site implicated in binding to formyl 
peptides at low concentration and in binding to S. aureus inhibitor (Osei-
Owusu et al. 2019, 1) It is quite possible that binding of this site directly by 
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Y. pestis LcrV and S. aureus FliprLike also serves to dampen the detection of 
their own bacterial peptides.  
Yersinia pestis is essentially a hyper-virulent derived strain of Yersinia 
pseudotuberculosis, diverged from the latter from approximately 10,000 years 
ago(Anisimov, Lindler, and Pier 2004). Y. pestis strains encode virulence 
factors on 32 Y. pestis-specific chromosomal genes, a unique pCD plasmid, 
and higher copy expression of Yersinia spp. virulence-associated 
plasmids(Perry and Fetherston 1997). The general trend in Y. pestis appears 
to be loss of functional metabolic genes in tandem with gain of virulence 
factors, as demonstrated by its incomplete pentose phosphate pathway and 
loss of other metabolism-associated genes(Hinnebusch, Jarrett, and Bland 
2017). The three biovars of plague have different metabolic capacities. The 
causative agent of the ancestral Justinian plague, biovar Antiqua, has been 
shown to reduce nitrate as well as metabolize glycerol, followed by Medievalis 
which cannot reduce nitrate, and Orientalis which cannot metabolize 
glycerol. In this manner, Yersinia species have evolved several differing 
sequences for LcrV that have been reported and studied in the literature 
(Anisimov, Lindler, and Pier 2004). It is not known whether these changes 
are due to genetic drift or molecular arms races between the interfaces of host 
receptors and pathogen proteins.  
We found that Order Carnivora which possesses only a single copy of FPR2 
also has heightened signatures of positive selection. Interestingly, the branch 
in Carnivora predicted to be undergoing repeated bouts of episodic selection 
is also the branch which displays variable susceptibility to plague. This is 
particularly interesting, because as already mentioned, FPR1 can act as a 
plague receptor on immune cells in humans. This leads to the obvious 
question: in a mammal that is susceptible to plague infection but does not 
possess an FPR1, what then is the plague receptor?  
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Figure 10. Susceptibility to plague varies across carnivores, who lack FPR1, 
required for entry in human immune cells  
Some mammals have done away with FPR1 function entirely, and no longer 
have a working copy of FPR1 (such as Canids), here we show FPR2 may/may 
not be able to act as a plague receptor in species that have lost functional 
FPR1. Many immune receptor gene families such as MHC, CD1, TLR to 
name a few, expanded in number (and in many cases evolved specific 
functions) via gene duplication events. For the primate FPR family of genes, 
we show that encoding proteins with similar properties may be a drawback 
since pathogens can exploit similarities to gain access to the host by 
alternative means. 
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Some mammals have done away with FPR1 function entirely, and no longer 
have a working copy of FPR1 (such as Canids), here we show FPR2 may/may 
not be able to act as a plague receptor in species that have lost functional 
FPR1. Many immune receptor gene families such as MHC, CD1, TLR to 
name a few, expanded in number (and in many cases evolved specific 
functions) via gene duplication events. For the primate FPR family of genes, 
we show that encoding proteins with similar properties may be a drawback 
since pathogens can exploit similarities to gain access to the host by 
alternative means.  
Some mammals have done away with FPR1 function entirely, and no longer 
have a working copy of FPR1 (such as Canids), here we show FPR2 may/may 
not be able to act as a plague receptor in species that have lost functional 
FPR1. Many immune receptor gene families such as MHC, CD1, TLR to 
name a few, expanded in number (and in many cases evolved specific 
functions) via gene duplication events. For the primate FPR family of genes, 
we show that encoding proteins with similar properties may be a drawback 
since pathogens can exploit similarities to gain access to the host by 
alternative means.  
It is unclear in mammals with only one FPR such as in most carnivores 
which only possess a single copy of FPR2, whether FPR2 can act as a plague 
receptor. Presumably the FPR2 receptor was immune to plague hijacking in 
humans prior to its emergence, since Denisovan DNA suggests the sequence 
of FPR2 has not diverged at sites under selection compared to extant FPR2. 
This is consistent with our results, which show lack of binding to LcrV 
protein (Figure 5), which is required for cell injection of pathogen virulence 
factors.  
However, felines remain susceptible to plague, even though they lack the 
FPR1 receptor (Bevins et al.; Castle et al.). The canine lineage, however, 
which also lacks and FPR1 receptor and only possesses an FPR2 receptor is 
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relatively insensitive to plague, with most canines experiencing only minor 
illness, if any (Vernati et al.; Salkeld and Stapp). Interestingly, the arginine 
at site 190 is fairly well-conserved in carnivore FPR2, as well as in Human 
FPR2 and many primates except for the Snub-nosed monkeys and the 
Colobus and Ugandan Red Colobus. The carnivore lineage is predicted to 
have several sites under selection in FPR2, and it is possible that one or more 
of these sites is involved in plague resistance/susceptibility, if FPR2 is indeed 
a viable receptor for plague entry. C5AR, the complement receptor is another 
immune receptor with sequence similarity to FPR1 that could be an 
additional candidate for plague entry to the cell.  
However, as always in evolution the story is complex. The W190 mutation in 
humans associated with resistance to plague is also associated with an 
increased affinity for SARS- coronavirus-related peptides, and a decreased 
affinity for formylated peptides (Mills). It is possible that the recent 
pandemic will have a selective effect for the W190 allele with the additional 
benefit of increased resistance to future plague outbreaks. Given the results 
of our analysis in S. aureus showing the importance of the region 
surrounding site 190 for ligand binding, further studies testing the trade-offs 
in plague susceptibility and ligand recognition for single nucleotide 
polymorphisms at this site would be valuable to understanding how hijacking 
this receptor might affect host:pathogen interactions broadly. 
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Figure 11. FPR1 site 190R is required for plague entry to the cell. FPR2 
shows signatures of positive selection at this site, which appears to be an 
important site for S. aureus inhibitor binding  
Other microbial interactions with formyl peptide receptors.  
Formyl peptide receptors in both human and cat have been shown to detect 
viral signatures of clinically relevant human immunodeficiency virus (HIV) 
and feline immuno-difficiency virus (FIV) respectively (Ding et al.; Mills). 
This detection appears to have a preference for the R190 versus the W190 
polymorphism in FPR1, suggesting that pressure to maintain the R190 allele 
to detect of the FIV peptide may be in direct opposition to fixing the W190 
allele in the population, despite its plague resistance effects. It is possible 
that detecting these viral signatures confers fitness benefits resulting in 
selective pressure to maintain the receptor despite the vulnerability to plague 
infection, in addition to fitness effects conferred by innate immune detection 
of bacterial peptides.  
Bridge to Chapter IV 
Studies in formyl peptide receptors across multiple species suggest that there 
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are forces at play in the relationship of genotype-phenotype beyond simply 
sequence divergence affecting function. Three of the most divergent proteins 
from primate in our analysis (Bonobo FPR1, Human FPR2 and Capuchin 
FPR2) showed similar binding profiles to FliprLike and enterotoxin that were 
not shared by Old World Monkeys studied. For a receptor as promiscuous as 
the formyl peptide receptor, studies addressing dominant forces driving 
evolution will be challenging. However, we did identify a region of the protein 
that appears to be extremely important for tuning ligand affinity. 
Identification of these hotspots can direct practical applications such as drug 
design or horizon scanning for mutations in pathogen-associated proteins 
that may be associated with extreme consequences for the host. Chapter IV 
continues the pursuit of understanding how sequence diversity affects the 
function of immune receptors, using a very different system. The CD1 family 
studied in the next chapter is unique in that it binds and presents lipid and 
lipopeptide molecules to T- cells. Due to the different characteristics of the 
ligands it presents, CD1 molecules have slightly different biology than the 
related MHC proteins. However, studies of CD1 molecules can have an 
impact on microbial pathogens such as Mycoplasma species which produce a 
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Introduction  
Early detection of pathogen-specific molecules by the im- mune system can 
mean the difference between resistance, latency, or succumbing to infectious 
disease. Previous studies have illustrated that host–pathogen protein 
interaction sur- faces are hotspots for repeated natural selection by influenc- 
ing resistance or susceptibility to infection (Daugherty and Malik 2012; 
Enard et al. 2016; van der Lee et al. 2017). Such conflicts between hosts and 
pathogens can give rise to a variety of evolutionary dynamics including Red 
Queen arms races (Van Valen 1973; Daugherty and Malik 2012), frequency-
dependent selection (Takahata and Nei 1990), and over-dominance (Hughes 
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and Nei 1990; Takahata and Nei 1990; Nei and Rooney 2005). Although 
vertebrate im- mune systems are tuned to recognize a wide variety of 
pathogen-associated macromolecules including DNA, RNA, lipids, and 
glycans, our understanding of host–pathogen evo- lutionary conflicts is 
largely restricted to protein–protein interactions (Sawyer et al.2005; Elde et 
al. 2009; Barber and Elde 2014; Choby et al. 2018). In the case of lipid and 
lip- opeptide antigens, the production of a functional molecule involves the 
synthesis of precursors that are further processed by enzymatic 
modifications. As such, evolutionary dynamics involving these 
macromolecules and their host receptors may be distinct from protein–
protein interactions.  
The major histocompatibility complex (MHC) superfamily comprises a variety 
of cell surface proteins which present self and foreign antigens to T-cells. 
Recognition of foreign anti- gens by T-cell receptors (TCRs) leads to T-cell 
activation and initiation of an adaptive immune response (Frank 2002). 
Multiple evolutionary forces are hypothesized to contribute to the immense 
diversity in MHC haplotypes, including over- dominance wherein increased 
heterozygosity is favored by selection and polymorphisms are maintained 
over time (Takahata and Nei 1990). In addition to class I and class II MHC 
molecules which present peptide antigens, the paralo- gous cluster of 
differentiation 1 (CD1) and MR1 molecules have been shown to present lipid 
and lipoprotein antigens to T-cells (Blumberg et al. 1995; Barral and Brenner 
2007; Birkinshaw et al. 2015; Moriet al.2016; Zajonc and Flajnik 2016). CD1 
molecules display rare and infrequent polymor- phism with limited genetic 
diversity within humans and other populations relative to class I and II MHC 
(Han et al. 1999; Golmogghaddam et al. 2013). The MHC and CD1 gene fam- 
ilies therefore appear to have experienced divergent evolutionary paths after 
their duplication from a common ancestor with respect to antigen recognition 
and population genetic variation. CD1 paralogs are divided into groups, 
whereby group 1 CD1 family members (including human CD1a, CD1b, and 
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CD1c) present antigen primarily to cyto- toxic CD8þ T-cells (Mori et al.2016). 
Group 2 CD1 molecules (including CD1d in humans) present antigens to 
invariant natural killer (iNK) T-cells (Pereira and Macedo 2016).  
CD1 and MHC (fig. 1A) arose in jawed fishes with the advent of the B-cell 
and T-cell immune receptors during the genesis of the adaptive immune 
system of vertebrates (Barral and Brenner 2007). After the gene duplications 
that gave rise to ancestral MHC and CD1, vertebrate CD1 paralogs expanded 
through repeated duplication events (Dascher 2007). This initial expansion 
was followed by differential pseu- dogenization and expansion of CD1 
paralogs to various degrees across vertebrate species (Rogers and Kaufman 
2016). As such, CD1 gene content varies widely across verte- brates: primates 
have a single copy of the CD1A paralog, mice possess none, dogs encode six, 
and horses possess five (Dascher 2007). In primates, CD1D is believed to 
represent the most deeply conserved member of the CD1 family (Salomonsen 
et al.2005). CD1d receptors can display antigen to specialized iNKT-cells, 
which are able to mount an earlier response to infection reflecting their dual 
role in innate and adaptive immunity (Pereira and Macedo 2016). Current 
evi- dence indicates that human CD1e does not present antigen (Garcia-Alles 
et al. 2011) but rather assists in antigen loading onto CD1d in lysosomes and 
endosomes (Cala-De Paepe et al. 2012). This wide range of responsive T-cell 
types along with evidence that these nonclassical T-cell types mount an early 
immune response to infection (Godfrey et al. 2015) makes human CD1-
expressing cells surprisingly flexible responders to infections even with their 
lack of exceptional sequence variation.  
CD1 molecules possess an extracellular domain containing a subsurface 
hydrophobic-binding pocket used to present antigen to CD1-restricted T-cells 
(fig. 1B) (Barral and Brenner 2007). During the adaptive immune response, 
CD1 on the surface of antigen-presenting cells activates T-cells by displaying 
specific classes of hydrophobic ligands to TCRs (fig. 1C) (Blumberg et al. 
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1995; Barral and Brenner 2007; Chancellor et al.2018). According to 
structural studies, CD1a has the smallest of the human CD1-binding pockets 
with a volume of about 1,280 A’ (Ly and Moody 2014). After the gene 
duplication event that gave rise to this paralog, CD1a likely evolved to 
present either self-lipids or small ex- ogenous lipopeptides (Mori et al.2016). 
Consistent with this hypothesis, CD1a has been crystallized in complex with 
self- lipids sphingomyelin, lysophosphatidylcholine (Birkinshaw et al. 2015), 
sulfatide (Zajonc et al. 2003), as well as the my- cobacterial lipopeptideanalog 
didehydroxy-mycobactin (Zajonc et al. 2005). The binding pocket of human 
CD1a is composed of a double-chambered cavity termed the A0 and F0 
pockets with a single (A’) portal that coordinates the pre- sentation of lipid 
antigen to the TCR (fig. 1B) (Zajonc et al. 2005). The TCR lands just above 
the A’ pocket on a surface termed the A’ roof (Zajonc et al. 2005). The 
diminutive size of the CD1a A’ pocket is thought to be formed by the electro- 
static interaction of the two side chains belonging to the A’ roof that also 
draw the two parallel alpha helices of the pocket in close proximity, whereas 
an amino acid sidechain blocks the base of the pocket thereby limiting size of 
tail groups that can be accommodated (in human CD1a this amino acid is 
valine 28) (Zajonc et al. 2003). Several other CD1 homologs, except for CD1c, 
lack this roof structure (Blumberg et al. 1995). CD1a does not feature a late 
endo- somal targeting element and does not require low pH for antigen 
binding as is the case for other CD1 proteins such as CD1b, CD1c, and CD1d 
(Chancelloret al.2018).  
The immense diversity of the MHC family within and be- tween populations 
at surfaces necessary for peptide antigen recognition has made these genes 
classic study systems of adaptive protein evolution (Danchin and Pontarotti 
2004; Castroet al. 2015; Grimholt 2016). CD1 molecules possess similar 
structure and function to class I and II MHC proteins, although their relative 
lack of diversity at the population level has been attributed to a lack of 
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diversity in their cognate lipid ligands. Although variation in pathogen-
derived lipids has been implicated in host immune recognition and virulence 
(Chandler et al. 2020), the potential for lipid antigens to pro- mote 
evolutionary conflicts with host species is unclear. In the present study, we 
used the CD1 family as a system to inves- tigate the diversity and evolution 
of lipid antigen recognition by the vertebrate immune system.  
Results  
Diversification of the CD1 Gene Family in Primates  
A comparison of MHC class I and CD1 protein structures illustrates the 
homology between these antigen presentation molecules (fig. 1A). CD1 
presents antigen to the TCR with the lipid tail groups tucked into the 
hydrophobic pocket and head groups exposed where they are “read” by the 
TCR (fig. 1B). Distinct CD1 molecules present antigen to a wide variety of T-
cell types (fig. 1C) (Godfrey et al. 2015). To assess patterns of genetic 
diversity among primate CD1 family members, we first assembled a 
collection of simian primate CD1 homologs from publicly available genome 
databases and generated a phylogenetic gene tree using PhyML (fig. 1C and 
supplementary fig. S1, Supplementary Material online). The five human CD1 
paralogs are present in the majority of pri- mate genomes surveyed, allowing 
us to reliably compare structural and genetic diversity within this family. A 
compar- ison of the sequences between CD1 orthologs revealed a striking 
degree of diversification, particularly in the MHC- like domain responsible for 
lipid antigen presentation (fig. 1D). To assess the potential consequences of 
this varia- tion on CD1 function, we plotted the structural conservation 
among primate CD1a orthologs using color by conservation (Mura et al. 2010) 
(fig. 1D and E). Our analysis revealed several hotspots of high amino acid 
divergence among CD1 mole- cules, focused on both interior regions of the 
antigen-binding pocket as well as surface helices that are known to contact 
the TCR. Together our results indicate that, despite their limited 
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polymorphism within populations, CD1 paralogs exhibit a high degree of 
genetic divergence between simian primate species.  
 
FIG. 12. Diversity of the CD1 gene family in primates. (A) Ribbon diagrams 
of human CD1a (PDB ID: 5J1A) and MHC (PDB ID: 1AKJ) with alpha 
helices highlighted in red, beta-sheet in purple, loops in yellow. (B) 
Illustration of the CD1-TCR interaction where CD1 bind lipid tails in a 
hydrophobic pocket with polar head groups typically exposed. The TCR (gray) 
“reads” the displayed antigen leading to T-cell activation. (C) Cladogram 
representing phylogenetic relationship of primate CD1a-e paralogs used in 
this study with surfaces generated in PyMol and antigen- binding pockets 
outlined in yellow (PDB IDs: 5J1A, 4ONO, 4MQ7, 3S6C). TCR types that 
recognize each CD1 paralog are also indicated. (D) Primate CD1a diverges 
most in the lipid-binding domain, which may alter pocket morphology and 
TCR interactions. Most of the sequence divergence in the primate CD1a 
proteins is predicted to exist in the beta-sheet that transects the center of the 
protein with some variation in the central surface region. RMSD, root mean 
square deviation. (E) Structural features of the CD1a receptor. Labels 
showing location of A’ Roof, F’ portal.  
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Signatures of Repeated Positive Selection Acting on Primate CD1 Genes 
Given their relative lack of within-population diversity, we were surprised by 
the elevated genetic divergence between primate CD1 orthologs. Previous 
studies of CD1A genetic diversity in humans revealed only three low-
frequency poly- morphisms (Han et al. 1999). Across primates included in 
this study, however, only 52.8% sites are identical. We hypothe- sized that 
this variation could be the result of repeated positive selection in response to 
diverse lipid antigen struc- tures. To identify potential amino acid sites that 
may have been subject to repeated positive selection, we used the codeml 
package from PAML (Yang 2007) in addition to MEME (Murrell et al. 2012) 
and FuBar (Murrell et al. 2013) algorithms from the HyPhy software package 
to detect ele- vated dN/dS (x) at sites in CD1 paralogs across primates. 
Elevated x values were detected for all CD1 family members (fig. 2A) with 
the exception of CD1b, consistent with elevated nonsynonymous substitution 
rates associated with positive selection. We noted that the majority of 
rapidly-evolving sites among CD1 paralogs were focused in the MHC-like 
domain sites between CD1a orthologs cluster to a region of the pro- tein near 
the center of the binding pocket and around the outer surface (fig. 2B). We 
grouped all of the rapidly-evolving sites we identified in this study into three 
categories: residues located at or near the TCR landing site (the A’ roof in the 
human structure), residues within the binding pocket, and residues in the N-
terminus for which we have no structural information. Overall, predicted 
structural features do not cor- relate well with phylogenetic relatedness, 
consistent with multiple lineages undergoing episodic selection (figs. 2C and 
3A).  
Accelerated Evolution of the CD1a-TCR Interface  
To assess how variation in CD1a may influence immune functions in 
primates, we used I-TASSER to generate pre- dicted structures of several 
CD1a orthologs (fig. 3A). Of the hominoid structures modeled, human, 
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bonobo, and orangu- tan have remarkably different topologies at the TCR-
CD1a interface as well as the geometry of the internal binding pocket (fig. 
3A). The morphologies of the binding pockets vary widely, most notably in the 
crab-eating macaque which is predicted to contain one main and two 
accessory portals, with a narrow meandering channel (fig. 3A, bottom panel). 
The length and volume of the pockets limit the types of lipid tail groups that 
can be accommodated, whereas the size and location of the portals have 
effects on how well the T-cell receptor can read the antigen presented 
(Birkinshaw et al. 2015).  
In human CD1a, the A’ roof is hypothesized to aid in determining whether an 
antigen will elicit an immune response by supporting interactions with the 
TCR and assisting in display of the ligand head-group (fig. 3B) (Zajonc et al. 
2005; Birkinshaw et al. 2015). The predicted orangutan CD1a structure lacks 
an A’ roof entirely (fig. 3C), whereas bonobo CD1a possesses two portals. 
Additionally, it has been speculated that disruption of hydrogen bonding 
between R73, R76, and E154 that form the A’ roof may indicate whether a 
given ligand will stimulate TCR activation (Birkinshaw et al. 2015). 
However, several of the CD1a structures are predicted to form an A0 roof 
that does not depend on this particular interaction. For example, crab-eating 
macaque and olive baboon CD1a are predicted to form a relatively unique A0 
roof composed of an R73/153Q linkage that does not involve R76 (fig. 3C). The 
TCR does not recognize CD1a-bound ligands without ade- quate projection of 
lipid head groups, and it is likely that hydrogen bonding between the head 
groups of smaller ligands and residues that make up the portal are important 
for display. Headless ligands buried in the CD1a pocket, for example, can 
result in T-cell auto-reactivity (de Jong et al. 2010). Site 153, which is highly 
variable across primates (fig. 2D) has been shown to form a hydrogen bond in 
human CD1a to the head group of self- antigen lysophosphatidylcholine and 
sulfatide in addition to its role in forming the A0 roof (Zajonc et al. 2003; 
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Birkinshaw et al. 2015). This site bears a glycine in orangutan, with no 
ability to form an A0 roof or salt bridges with ligand (fig. 3C). Together, these 
predicted struc- tural differences suggest that natural selection may have had 
a significant impact on the ability of CD1a to display self or foreign lipid 
antigens across related primates.  
Structural Remodeling of the CD1a Antigen-Binding Pocket 
To determine whether the structural differences observed across CD1a 
paralogs are likely to have functional consequen- ces for antigen recognition, 
we applied a ligand-docking approach using AutoDock Vina. We were 
particularly interested to test affinity differences between endogenous and 
exoge- nous lipid ligands, since the current model for CD1a antigen 
presentation is a swapping mechanism wherein lower affinity endogenous 
ligand is replaced at the cell surface by higher affinity exogenous ligand. We 
used ligands previously crystal- lized in complex with human CD1a in our 
studies since there is a wealth of structural information available on these 
par- ticular binding interactions. In our docking simulations, we found that a 
single loop region is required to redock all ligands in the CD1a-binding 
pocket. We assigned flexibility to this region for all the structures tested, as 
well as any nonbonded sidechains in the region of the portal (supplementary 
fig.S2, Supplementary Material online). We believe this is likely the region 
responsible for conferring flexibility in the native CD1a, which must be 
flexible enough to accommodate ligands with a diversity of molecular weights 
(molecular weight of urushiol is 330 g/mol, dideoxymycobactin is 838 g/mol).  
We next measured predicted CD1a-binding affinities for the panel of lipid 
ligands including endogenous ligands sphingo- myelin, sulfatide, 
lysophosphatidylcholine, and exogenous li- gand dideoxy-mycobactin (DDM) 
(fig. 4A and supplementary figs. S5–S7, Supplementary Material online). We 
chose these lipids because published structural information exists for each 
ligand bound to the human CD1a receptor. Given that CD1a is believed to 
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swap endogenous lipids for exogenous lipids based on differences in relative 
binding affinities, we then estimated the likelihood of a lipid-swap using our 
panel of ligands. We calculated the fold differences in Kd (dissociation 
constant) between the highest affinity endogenous lipid and compared this to 
the Kd of the exogenous ligands. Crab-eating macaque, snub-nosed monkey, 
olive baboon, capuchin, mangabey, bo- nobo, and human were predicted to 
swap out endogenous for DDM (fig. 4B). It is worth noting in this case that 
we assume the endogenous lipid with the lowest Kd is also present in 
abundance, which we can not know for certain in vivo. It has been shown in 
previous studies that human CD1a molecules bind to a diverse repertoire of 
lipid types in vitro (Birkinshaw et al. 2015). Since lipid profiles are not 
available for all cell types in the primates we studied, we chose this 
simplification as a rough estimate for the feasibility of lipid swapping.  
A notable result from these ligand docking predictions was that binding 
profiles failed to group by species phylogeny, consistent with branch-site test 
results that detected several branches undergoing multiple bouts of episodic 
positive selection (supplementary fig.S5, Supplementary Material online). 
Unlike in humans where the largest binding pocket (CD1b) (Ly and Moody 
2014) also has the most promiscuous ligand- binding profile, ligand docking 
predictions do not group higher affinity binding with predicted pocket volume 
(fig. 4C and which is responsible for lipid binding (fig. 2A). These results 
suggest that multiple members of the CD1 family have undergone repeated 
episodes of positive selection in simian primates specifically within regions 
important for lipid antigen presentation.  
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FIG. 13. Evidence of repeated positive selection among primate CD1 
orthologs. (A) Amino acid sites exhibiting strong signatures of positive 
selection (elevated dN/dS) are highlighted in teal and mapped onto 
corresponding crystal structures. Alpha helices are denoted in red, beta-sheet 
in purple. (PDB IDs: 5J1A, 4ONO, 4MQ7, 3S6C). Table summarizes positions 
in CD1 paralogs contributing to signatures of positive selection as well as 
statistics from PAML M7-M8 model comparisons. (B) Sites with elevated 
dN/dS indicative of positive selection (teal) cluster in the MHC domain of 
CD1a protein (PDB ID: 5J1A). Alpha helices denoted in red, beta-sheet in 
purple. (C) Multiple sequence alignment of primate species used to calculate 
dN/dS ratios for CD1a paired with phylogenetic species tree highlighting the 
branches (teal) predicted by aBSREL to be undergoing episodic positive 
selection.  
49 
Having detected evidence of positive selection acting on several CD1 family 
members, we chose CD1a for additional in-depth analysis. CD1a has less 
stringent lipid loading requirements than other CD1 homologs as it does not 
require a reduced pH environment encountered in late endosomes, nor does it 
have a known adapter protein required for antigen loading (Barral and 
Brenner 2007). For these reasons, we an- ticipated that empirical and 
molecular modeling studies of antigen recognition would be less complex for 
CD1a than other paralogs. CD1a has been shown to present mycobac- terial 
antigens from the cell surface where it interacts with langerin on Langerhans 
cells (Mizumoto and Takashima 2004), a specialized dendritic cell type that 
surveys epithelial monolayers for molecular indicators of infection.  
To determine what domains of CD1a are subject to pos- itive selection, we 
mapped the sites with high x values from our previous analysis. Results show 
clustering of rapidly evolv- ing sites in the MHC-like domain, similar to those 
observed with other CD1 paralogs (fig. 2B and supplementary figs. S2– S4, 
Supplementary Material online). These sites also map to regions where CD1a 
is likely to interface with lipid antigen or the TCR, suggesting that selection 
may have acted to alter lipid-binding and T-cell interactions. The majority of 
variable supplementary fig.S8, Supplementary Material online). These 
findings indicate that predicted structural alterations in the CD1a ligand-
binding pocket have significant impacts on recog- nition of both endogenous 





FIG. 14. Structural modeling illustrates diversity at the CD1a T-cell 
interaction interface. (A) Predicted attributes of various primate CD1a 
structures. Surface characteristics across selected primates reveal differences 
in portal size, number of portals, and pocket morphology. Portals where T-cell 
receptor “reads” head group are highlighted with gray/yellow outlines. Pocket 
morphologies and electrostatic properties are shown below surface models. 
(B) PyMol generated top-view of human CD1a bound to dideoxy-mycobactin 
(PDB ID: 1XZO). Rapidly-evolving positions 73 and 153 coordinate head 
groups of antigenic ligand. Note hydrogen bonding between head group and 
153E. (C) Primate CD1a A0 roof predicted structures where CD1a interacts 
with TCR. Notably, the orangutan model does not form roof structure due to 
mutation at site under selection. Olive baboon and crab-eating macaque form 
A’ roof with residue of differing property at site 153.  
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Modeling the Effects of Rapidly-Evolving Sites on Antigen Presentation by 
CD1a 
We next assessed how variation at single rapidly-evolving posi- tions in the 
CD1a-binding pocket may alter lipid antigen rec- ognition. Using PyMol, we 
substituted single extant amino acids for the ancestral amino acid at sites 
undergoing positive selec- tion (ancestral sites predicted by DataMonkey 
package SLAC; Pond and Frost 2005) and used these altered structures in 
our ligand-docking simulation. We then tested the effects of mutations in 
positively-selected sites on crab-eating macaque CD1a. We observed that the 
W98G substitution (which replaces a bulky tryptophan at the base of the 
pocket for the smallest residue, ancestral glycine) significantly 
increasedbinding affinity for endogenous lipids in crab-eating macaque, thus 
making it unlikely that swapping for DDM would occur (fig. 5A). This 
mutation appears to have similar effects in other genetic back- grounds as 
well, including humans (fig. 5A and B). Analysis of the binding pose in crab 
macaque W98G bound to lysophosphatidylcholine shows the ligand buried in 
the pocket without an exposed head group (de Jong et al. 2010) (fig. 6A). This 
provides a possible explanation for why the reduction in accessible pocket 
volume may be beneficial, both for lipid swap- ping and TCR ligand 
recognition. In the human V98W muta- tion, we noticed that the tail group 
accesses deeper regions of the pocket, which may partially explain the higher 
affinity for DDM seen in this model (fig. 6B).  
To probe our system further, we used the genetic back- ground of snub-nosed 
monkey to simulate the effects of muta- tions since it encodes primate 
consensus residues at positions with elevated dN/dS. We mutated seven sites 
that appear at the interaction interface to the ancestral sites at all loci, 
resulting in a protein that is not likely to swap endogenous ligand for DDM 
by our predictions (supplementary fig.S6, Supplementary Material online). 
Smaller effect mutations were identified when introducing combinations of 
mutations in crab-eating macaque at po- sition 114 where tyrosine appears to 
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lower affinity for endogenous ligand and increases affinity for mycobacterial 
li- gand slightly (supplementary fig.S7, Supplementary Material online). 
Taken together, several species are predicted to bind DDM with relatively 
high affinity but may not necessarily present exogenous antigen due to 
equally or greater affinity for endogenous lipid. This suggests that selective 
pressure may exist to decrease affinity for endogenous ligand in conjunction 
with increased affinity for exogenous antigens, resulting in increased 
effectiveness of CD1a-dependent immune responses. We observed that even 
single substitutions in rapidly-evolving sites substantially alter both 
endogenous and pathogen-derived lipid antigen recognition, providing further 





FIG. 15. Divergence of CD1a shapes predicted endogenous and exogenous 
lipid antigen affinities. (A) Plot of relative Gibbs free energy values for all 
ligands tested by ligand docking predictions using AutoDock Vina. Lowest 
energy values for each set are plotted. Sulfatide, sphingomyelin, 
lysophosphatidylcholine are endogenous lipid ligands. Dideoxymycobactin 
(DDM) is a synthetic lipid analog of Mycobacterium tuberculosis siderophore 
mycobactin. Urushiol is the etiological agent of poison ivy rash. (B) Lipid-
swapping predictions based on predicted Kd (dissociation constant) from 
docking studies. (C) Predicted pocket volume for CD1a orthologs. Legend: 
Hum, Human; Chp, Chimpanzee; Bon, Bonobo; Gor, Gorilla; Orn, Orangutan; 
Oli, Olive Baboon; Grn, Green Monkey; Mng, Mangabey; Crb, Crab-eating 




FIG. 16. Rapidly-evolving positions in CD1a are sufficient to modulate 
predicted affinity for lipid antigens. (A) Mutation of site 98 to tryptophan in 
human CD1a (olive baboon and crab-eating macaque share this amino acid at 
this position) results in increased predicted binding affinity to DDM, with 
overall fold increase between endogenous ligand and DDM. Mutation of 
tryptophan at site 98 in crab-eating macaque to ancestral glycine results in 
higher binding affinity for all endogenous ligands tested, and loss of feasible 
lipid-swapping and DDM presentation. (B) Mutation of site 98 to tryptophan 
in snub-nosed monkey CD1a results in increased predicted binding affinity to 
DDM. Colobus, which is not predicted to swap endogenous ligand for DDM, 
also increases spread between binding affinities. In colobus, however, it is a 
decrease in affinity for endogenous lipid rather than increase in DDM affinity 
that is responsible for the fold change.  
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FIG. 17. Conceptual framework for lipid-driven diversification of CD1 
molecules. (A) Crab-eating macaque CD1a, which encodes a tryptophan in 
position 98, is predicted to lose the ability to present self-lipid 
lysophosphatidylcholine when this position is mutated to the consensus at 
this site, glycine. An overlay of the differences in pocket morphology shows 
how the tryptophan limits access to the deeper chambers of the pocket. (B) 
Humans possess a valine at position 98, which has been proposed to act as a 
barrier limiting larger ligands access to the pocket. When this residue is 
mutated to a tryptophan in silico, further decreasing access to the deeper 
chambers of the pocket, the ability to swap out endogenous for exogenous 
ligand is improved, suggesting that a large hydrophobic residue in this 
position may be beneficial in the context of Mycobacterium tuberculosis 
infection in primates. Cartoons were informed by analysis of Autodock Vina 
docking results analyzed in PyMol. (C) Conceptual framework for lipid-driven 
evolution of CD1, resulting in accelerated evolution and rapid diversification 
of host immune receptors. Lipid biosynthesis pathways are complex and 
interdependent, thereby adding levels of complexity that may slow the rate at 
which pathogens can successfully evolve new lipid antigens. Figure created 






Overdominance has been proposed as an important force acting on MHC 
genes producing diversity across the gene family (Hughes and Nei 1990). CD1 
genes exhibit limited sequence variation within humans (Blumberg et al. 
1995), which suggests overdominance is likely not a major factor shaping the 
evolution of this family. Rather, our observations of elevated dN/dS be- tween 
CD1 orthologs and limited polymorphism within species are most consistent 
with a history of repeated selective sweeps  
driven by positive selection. Moreover, the patterns of diver- gence in CD1, 
with amino acid variation enriched within the MHC-like domain, supports 
the hypothesis that lipid antigen recognition and presentation are the 
functional drivers of this divergence. These patterns are also observed in 
MHC genes (which are also undergoing positive selection), with elevated x at 
hotspots in the MHC antigen recognition groove (Hughes and Nei 1990; 
Manlik et al. 2019). The electrostatic property variation in lipid ligands is 
found almost exclusively in the head-groups, with differences in the tail 
groups restricted to length and ge- ometry of the hydrocarbon tails. As these 
tail groups have the most physical contact with CD1-binding pockets, amino 
acids changes affecting the length and geometry of this pocket deter- mine 
which hydrophobic chains can be accommodated. Patterns of evolution 
observed in CD1 could reflect a classical arms race in which host receptors 
and a subset of microbial antigens antagonistically coevolve through time. 
Alternatively, selection in a fluctuating environment where the fitness 
benefit of recognizing a particular lipid antigen changes over time could also 
produce elevated patterns of divergence in CD1. Coevolution between lipid 
antigens and host proteins would likely involve mutations in microbial genes 
responsible for lipid processing or modification (fig. 6C). Future studies could 
aid in determining how variation in lipid-modifying genes shapes CD1- 
dependent immune responses to specific pathogens.  
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Collectively our results suggest that, for species predicted to undergo lipid 
swapping of endogenous lipid for mycobactin, natural selection may have 
acted to decrease affinity for endog- enous ligand while increasing affinity for 
exogenous antigen by CD1a. We observed that a single substitution can 
significantly alter the predicted effects of ligand-binding affinity, with poten- 
tial consequences for antigen presentation (fig. 5A and B). Notably, a major 
effect mutation identified in species undergo- ing episodic bouts of selection 
has the ability to reliably increase affinity for DDM and/or decrease the 
affinity of endogenous ligands by CD1a (fig. 5). Our analyses also indicate 
other residues determining binding pocket volume in human CD1a are un- 
dergoing repeated positive selection across primates (fig. 2). In particular, 
valine 28 has been reported to form a molecular barrier that acts as a size-
limiting determinant for antigen bind- ing (Zajonc et al. 2003). Notably, New 
World monkeys encode a smaller residue (glycine) at this position. 
Replacement of valine with glycine might be expected to expand the size of 
the binding pocket. However, our molecular modeling indicates that the 
binding pocket in the New World monkey lineages is predicted to be smaller 
than even the crab-eating macaque or mangabey, which bear an isoleucine 
and a threonine, respectively, at this same site. These observations suggest 
that molecular determinants of binding pocket volume and morphology are 
complex and influenced by a combination of variable amino acid sub- 
stitutions. Additionally, the size of the binding pocket does not appear to 
correlate with feasibility of DDM presentation. This is notable because in 
other CD1 molecules multiple lipids can be accommodated, negating the need 
for a stronger binding affinity for exogenous ligand. In fact, other CD1 
molecules such as CD1b may even require “spacer” lipids (Garcia-Alles et al. 
2011). These observations may reflect selection acting to produce a binding 
pocket that is able to swap out endogenous ligand without the need for a 
loading protein as seen in other CD1 paralogs. This feature enables CD1a to 
directly surveil the environment for pathogen-associated molecules, a 
potential advantage compared with the other CD1 molecules which require 
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lysosomal processing and accessory protein loading before antigen 
presentation can occur at the cell surface.  
In order for a microbial pathogen to evolve alternative lipid antigen 
structures, mutations likely occur in genes responsible for synthesis or 
modification of the lipid antigen. Mutations in processing and production of 
lipids will most likely have effects on steps of the biosynthesis pathways that 
are down- stream of the mutated enzyme (fig. 6C). In the future, it would be 
intriguing to test whether primate CD1a orthologs have evolved to detect 
other lipid types or variations of mycobactin derived from other pathogen 
sources. According to data from NIHTPR’s AceView (Thierry-Mieg and 
Thierry-Mieg 2006), gene expression of CD1a/c is exceptionally high in  
tissues in pig-tailed macaque. Additionally, certain orthologs such as the 
marmoset CD1a exhibit very low gene expression (Thierry-Mieg and Thierry-
Mieg 2006) and may be undergo- ing rapid birth-and-death evolution (Nei 
and Rooney 2005) and eventual pseudogenization. Such observations would 
be consistent with findings of dynamic CD1 gene duplication and loss across 
vertebrates (Nei and Rooney 2005). The sig- nificance of changes in 
endogenous lipid presentation will also be an area for important future 
investigation. Certain isoforms of sulfatide, for example, are associated with 
cancerous cells and when bound to CD1a can prime T- cells(Takahashi and 
Suzuki 2012). It has also been shown that presentation of endogenous 
ceramides by CD1d is asso- ciated with the ability to detect disease (Paget et 
al. 2019).  
CD1 molecules possess the ability to bind and present hydro- phobic antigens 
from a variety of pathogens, many of which likely remain to be described. It is 
notable, however, that the majority of CD1 antigens identified to date are 
derived from pathogenic mycobacteria including Mycobacterium tuberculosis, 
the causative agent of tuberculosis in humans. Tuberculosis remains a 
devastating human public health burden, recently accounting for more 
59 
deaths due to infectious disease than any other single pathogen (Forrellad et 
al. 2013). It is tempting to speculate whether mycobacterial antigens have 
indeed imposed particularly strong selective pressure on CD1 molecules 
during animal evolution. Given the limited effectiveness of the current 
tuberculosis vaccine (Schito et al. 2015; Gonget al.2018), addition of CD1-
targeted antigens in a next-generation vaccine could provide one avenue for 
increased efficacy (Gonget al.2018). Functional characterization of diverse 
CD1 orthologs beyond humans may reveal whether detection of 
mycobacterial antigens is a widely conserved feature in this family, as well as 
possible routes to enhance CD1-mediated immunity against M. tuberculosis. 
Alternatively, evolution-guided development of synthetic lipid antigens that 
confer increased activation of CD1- responsive T-cells could provide an 
alternative strategy to en- hance lipid-based vaccines.  
Although we focused our molecular modeling and simulation studies on 
CD1a, comparable signatures of positive selec- tion were identified in primate 
CD1c, CD1d, and CD1e. Further investigation of these receptors and their 
cognate antigens would greatly advance our understanding of the importance 
for CD1 diversity in the evolution of vertebrate immunity. For this study, 
Autodock Vina was used because published results show strong correlation 
between docking and experimental values (Trott and Olson 2009) especially 
when iterations are increased (Jaghoori et al. 2016) as we did in this study. . 
Additionally, Autodock Vina has been reported to perform well with lipid 
ligands specifically (Gathiaka et al. 2013). However, there is improved 
reliability when comparing dock- ing results from the same receptor molecule 
bound to variable ligands (Jaghoori et al. 2016). The main caveats of this 
analysis exist in the uncertainties inherent in the structural prediction 
models. I-TASSER predictions are often very good, but rely on availability of 
structural information on similar molecules in the database which may not 
be available (Yang and Zhang 2015).  
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Although lipids and other pathogen-derived macromolecules have long been 
appreciated as critical targets for host innate and adaptive immune 
responses, the potential for these factors to promote evolutionary conflicts 
with host species has been relatively unexplored. By combining comparative 
genetics and molecular modeling approaches, this study illuminates how lipid 
antigens have shaped fundamental features of primate immunity and the 
detection of globally devastating pathogens.  
Materials and Methods  
Phylogenetic Analyses  
A gene tree of primate CD1 was generated with PhyML (phy- logenetics by 
maximum likelihood) with Bayes selection crite- rion and 1,000 bootstraps 
(Yang 2007). Between 18–21 primate cDNA sequences were aligned for each 
CD1A-E gene using MUSCLE (supplementary fig. S8, Supplementary 
Material on- line), sequences were trimmed manually using the species phy- 
logeny as reported by Perelman et al.(2011). Our CD1A data set included all 
available nucleotide coding sequences (cDNA) for 19 primate species, with 
areas of ambiguity and stop codons removed. Positively selected sites for all 
CD1 genes were detected using the phylogenetic analysis by maximum likeli- 
hood (PAML) software package with F3X4 codon frequency model. Likelihood 
ratio tests compared pairs of site-specific models M1 with M2 (neutral and 
selection, respectively), M7 with M8 (neutral, beta distribution of dN/dS < 1; 
selection, beta distribution dN/dS > 1, respectively). Additional tests were 
per- formed which account for synonymous rate variation and re- 
combination, including FuBAR (Murrell et al. 2013) and MEME (Murrell et 
al. 2012), using the HyPhy software package (Murrell et al. 2012, 2013). We 
chose a stringent selection criteria for the sites we focused on in this study: 
PAML and FuBAR posterior probability of greater than or equivalent to 0.9, 
MEME P value of 0.1 or less. All sites analyzed (unless otherwise stated) fit 
these criteria under all three tests.  
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CD1a Structural Predictions  
The Eukaryotic Linear Motif resource (Kumar et al. 2019) (http://elm.eu.org/, 
last accessed February 12, 2021) was used to identify structural motifs from 
the primary amino acid sequence of CD1a. Primate CD1a structures were 
pre- dicted with amino acid sequences submitted to I-TASSER server (Yang 
and Zhang 2015) (https://zhanglab.ccmb.med. umich.edu/, last accessed 
February 12, 2021) to generate structures for analysis using PyMol, primate 
structural align- ment from 14 primate structures colored by conservation 
based on RMSD calculations from PyMol alignment 
(https://pymolwiki.org/index.php/Color_by_conservation, last accessed 
February 12, 2021) (Mura et al. 2010), CASTp for volume predictions, and for 
use in ligand docking simulations. To assess confidence in our structural 
predictions, isoform 1 of full-length human CD1a was analyzed (there are 
several crystal structures available for this molecule) with a C-score of �0.36. 
C-score values vary from -5, 2 with positive values indicating higher 
confidence, and only structures with C values between -1 and 2 were used for 
analysis. Structures were analyzed using PyMol (The PyMol Molecular 
Graphics System, Version 2.0 Schro ̈dinger, LLC). For binding pocket volume 
predictions, CASTp was used and the radius probe was set at 0.75 A ̊ for each 
iTASSER-predicted structure sub- mitted for analysis. The predicted volumes 
for all species were plotted using the Seaborn package in Python.  
Ligand Docking with AutoDock Vina  
Redocking with human CD1a was first performed to identify flexible residues 
required for all known ligands to redock in the same model. We calibrated 
our modeling by redocking known ligands in our human CD1a iTASSER-
predicted structure. According to our calculations, a comparison of CD1a 
crystal structures bound to the smallest and largest ligands (PDB ID 4X6D, 
1XZ0) yields an RMSD of 1.23A ̊. This suggests there is flexibility in the 
CD1a pocket, supported by a number of hydro- gen bonds between residues of 
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the main CD1a-binding domain alpha helices. Dorsal loop of alpha helix 2 
was identified as re- quired and made flexible in all primate CD1a structures 
analyzed. Receptors with amino acid side chains that occluded the binding 
pocket were also made flexible if not engaged in hydrogen bonds, and any of 
these additionally flexible residues (see Supplementary Material online for 
details). AutoDockTools 1.5.6 (Trott and Olson 2009) was used to prepare the 
ligands and receptors for ligand docking. AutoDock Vina was run in the 
command line and docking results were analyzed in PyMol and plotted with 
the Python Seaborn package. A Python script was written to perform KD 
calculations. Details of Vina settings in- cluding exhaustiveness, grid center, 
and x, y, z coordinates are available in the Supplementary Material online.  
Data Availability  
The data underlying this article are available in the article and in its online 






SUMMARY AND CONCLUDING REMARKS 
Contribution to the Field of Molecular Evolution  
Pathogens and parasites have evolved effective strategies to gain access to 
host resources. The immune system fends off these attacks, often through 
detection of pathogen associated molecules and clearance of infection. This 
results in interactions between host and pathogen that often take place at 
molecular interfaces of immune receptors that act as a first line of defense to 
infection. Such receptors must identify pathogen-specific molecules and 
mount an appropriate response. Due to the frequency of such high stakes 
interactions between immune receptors and pathogen- derived molecules, the 
immune system is under constant evolutionary pressure to innovate new 
modes of defense and detection, while the pathogen is under pressure to 
evade these efforts and mount offensive attacks. This dynamic evolutionary 
antagonism is the underlying phenomenon inspiring this work. Because 
proteins evolve functions through DNA modifications, we study the effects of 
nucleotide variation across related species and test how variation affects the 
dynamics of protein interactions. We find that phylogenetic relatedness is not 
always a predictable indicator of functional similarity in the systems we 
tested. In the first study in Chapter III, we found that presence of certain 
amino acids in ligand-binding hotspots are more likely to have an effect on 
whether a Staphylococcus aureus inhibitor binds to immune receptor than 
overall sequence homology. In the second study that comprises Chapter IV, 
we found a similar lack of correlation between predicted functional outcomes 
and familial relationship. Similar to the study in Chapter III, we found that 
certain sites could have an outsized effect on function that could be 
translated across multiple species. Interestingly, site-level similarities at 
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Figure S2. Pre-incubation with FliprLike before binding to S. enterotoxin B 
(n=1)  
 
Figure S3. FPR gene tree of primates 
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Figure S4. Few differences between Human FPR1 and Bonobo FPR1
 
Figure S5. Denisovan and modern-day human FPR1 sites under selection 
Lack of changes at positively selected sites suggests positive selection 
occurring in other mammalian/primate lineages in FPR1 and FPR2 in 






Figure S6. Indels removed in Cebus imitator NCBI cDNA are also present in 
Sapajus apella sequence  
 
 
Figure S7. Insertion of three nts removed in Cebus imitator NCBI cDNA are 





Figure S8. Alignment of region near FPR1 locus from Aotus nancymaae with 




Figure S9. Binding of f-MLF to Bonobo FPR similar characteristics to human 
FPR2 
  
Bonobo FPR1-fMLF in dark pink, FFSYEWK in cyan 
  













SUPPLEMENTARY MATERIAL FOR CHAPTER 
Supplemental Figures 1-8  
Figure S1. CD1 Primate Family Tree  
 
 
Phylogenetic relationship of primate CD1 homologs used in this study. Tree 
was generated in PhyML with 1000 bootstraps. Chicken CD1.1 was included 
as an outgroup.  
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Figure S2. Vina Settings: Grid box parameters and flexible residues  
 
 
Parameter settings for config file used to generate ligand docking models 
with Autodock Vina, including residues set as flexible which correspond to 
the loop residues between alpha helices 1 and 2, and any occluding residues 





Figure S3. CD1 family members recognize a variety of mycobacteria-derived 
and endogenous lipids 
 
 
Multiple mycobacterial lipids and lipoproteins are recognized by CD1 
receptors, suggesting that this bacterial family known for exotic lipids has 
been interacting with the CD1 receptors across an extended timespan.  
 
Figure S4. Sites under positive selection that differ from consensus, 
illustrated in a visual cartoon. Property differences in amino acids cluster 
around the portal and at the TCR interaction surface, while internal residues 





Figure S5. Plots of CD1a primate docking experiments by individual lipid. 









Figure S6. Snub-nosed monkey represents consensus at sites under selection. 
Ancestrally-predicted amino acids differ from consensus. Reversion of sites to 
ancestral state in snub-nosed monkey background results in lower affinity for 






















Figure S7. Additional amino acid changes confer minor increase in spread 
between endogenous and exogenous lipid. Small changes in affinity can be 
seen when other sites with high omega values are plotted in the Crab-eating 
macaque, such as site 114 which appears to have a similar effect to site 98, 
though smaller in magnitude, presumably due to the loss of bulky residue in 









Figure S8. Pocket volume does not correlate with lipid binding affinity. Plots 
of docking results were converted to Kd (dissociation constant) and plotted 
against predicted pocket volumes. Observations did not support a case where 



















Figure S10. CD1 Sequences used for PAML codeml analysis and multiple 
sequence alignments  
Sequences used for phylogenetic analysis with NCBI accession identification 
numbers.  
Primate CD1a, 18 species 
Homo sapiens, NCBI Reference Sequence: NM_001763.3; Macaca mulatta, 
NCBI Reference Sequence: NM_001145818.1; Pan troglodytes, NCBI 
Reference Sequence: XM_001169121.4; Macaca fascicularis, NCBI Reference 
Sequence: XM_005595550.2; Papio anubis, NCBI Reference Sequence: 
XM_003892864.5; Gorilla gorilla gorilla, NCBI Reference Sequence: 
XM_004027022.3; Pan paniscus, NCBI Reference Sequence: 
XM_024926560.2; Pongo abelii, NCBI Reference Sequence: XM_002809984.3; 
Aotus nancymaae, NCBI Reference Sequence: XM_012449747.1; 
Rhinopithecus bieti, NCBI Reference Sequence: XM_017868910.1; 
Rhinopithecus roxellana, NCBI Reference Sequence: XM_030935243.1; 
Colobus angolensis palliatus, NCBI Reference Sequence: XM_011928485.1; 
Piliocolobus tephrosceles, NCBI Reference Sequence: XM_023214151.2 Cebus 
capucinus imitator, NCBI Reference Sequence: XM_017503703.1; Callithrix 
jacchus, NCBI Reference Sequence: XM_002764268.4; Chlorocebus sabaeus, 
NCBI Reference Sequence: XM_007976629.1; Cercocebus atys, NCBI 
Reference Sequence: XM_012093252.1; Macaca nemestrina, NCBI Reference 
Sequence: XM_011769959.2  
Primate CD1b, 21 Species 
Homo sapiens, GenBank: AK303330.1; Papio anubis, NCBI Reference 
Sequence: XM_003892865.5; Theropithecus gelada, NCBI Reference 
Sequence: XM_025362870.1; Mandrillus leucophaeus NCBI Reference 
Sequence: XM_011978334.1; Cercocebus atys, NCBI Reference Sequence: 
XM_012093255.1; Chlorocebus sabaeus, NCBI Reference Sequence: 
XM_007976624.1; Macaca fascicularis, NCBI Reference Sequence: 
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XM_005541341.2; Macaca nemestrina, NCBI Reference Sequence: 
XM_011769969.2 
Rhinopithecus roxellana, NCBI Reference Sequence: XM_010387232.2; 
Colobus angolensis palliatus, NCBI Reference Sequence: XM_011957139.1; 
Piliocolobus tephrosceles, NCBI Reference Sequence: XM_023214158.2; 
Nomascus leucogenys, NCBI Reference Sequence: XM_003258651.4; 
Pan troglodytes, NCBI Reference Sequence: XM_513909.5; Pongo abelii, 
NCBI Reference Sequence: XM_002809978.3; Gorilla gorilla gorilla, NCBI 
Reference Sequence: XM_004027024.3; 
Pan paniscus, NCBI Reference Sequence: XM_003821008.2; Cebus capucinus 
imitator, 
NCBI Reference Sequence: XM_017503705.1; Saimiri boliviensis boliviensis, 
NCBI Reference Sequence: XM_003937886.2; Aotus nancymaae, GenBank: 
AY605931.1; Callithrix jacchus, NCBI Reference Sequence: XM_002760142.3  
Primate CD1c, 20 species 
Homo sapiens, Reference Sequence: NM_001765.3; Papio anubis, NCBI 
Reference Sequence: XM_021925284.2; Theropithecus gelada, NCBI 
Reference Sequence: XM_025393420.1; Mandrillus leucophaeus, NCBI 
Reference Sequence: XM_011969349.1; Macaca mulatta, NCBI Reference 
Sequence: NM_001145533.1; Macaca fascicularis, NCBI Reference Sequence: 
XM_005595546.2, Macaca nemestrina, NCBI Reference Sequence: 
XM_011769962.2, Rhinopithecus bieti, NCBI Reference Sequence: 
XM_017868926.1; Rhinopithecus roxellana, NCBI Reference Sequence: 
XM_010381246.2; Piliocolobus tephrosceles, NCBI Reference Sequence: 
XM_023214153.2; Colobus angolensis palliates, NCBI Reference Sequence: 
XM_011928487.1; Nomascus leucogenys, NCBI Reference Sequence: 
XM_003258650.2; Pongo abelii, NCBI Reference Sequence: XM_002809979.3; 
Pan paniscus, NCBI Reference Sequence: XM_003821009.3; Gorilla gorilla 
gorilla, NCBI Reference Sequence: XM_019025012.2; Pan troglodytes, NCBI 
Reference Sequence: XM_513908.6; Cebus capucinus imitator, NCBI 
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Reference Sequence: XM_017503701.1; Cercocebus atys, NCBI Reference 
Sequence: XM_012093253.1; Callithrix jacchus, NCBI Reference Sequence: 
XM_035279155.1  
Primate CD1d, 18 species  
Homo sapiens, NCBI Reference Sequence: NM_001766.4; Aotus nancymaae, 
NCBI Reference Sequence: XM_012449750.2; Rhinopithecus roxellana, NCBI 
Reference Sequence: XM_030935246.1; Cercocebus atys, NCBI Reference 
Sequence: XM_012093246.1; Papio anubis, NCBI Reference Sequence: 
XM_017948205.3; Macaca fascicularis, NCBI Reference Sequence: 
XM_005541342.2; Macaca nemestrina, NCBI Reference Sequence: 
XM_011769953.1; Chlorocebus sabaeus, NCBI Reference Sequence: 
XM_007976632.1; Pongo abelii,  
NCBI Reference Sequence: XM_024247050.1; Pan troglodytes, NCBI 
Reference Sequence: NM_001071804.1; Pan paniscus, NCBI Reference 
Sequence: XM_008974483.3 Macaca mulatta, NCBI Reference Sequence: 
NM_001033114.2; Gorilla gorilla gorilla, NCBI Reference Sequence: 
XM_019024988.2; Aotus nancymaae, NCBI Reference Sequence: 
XM_012449750.2; Saimiri boliviensis boliviensis, NCBI Reference Sequence: 
XM_010348509.1; Piliocolobus tephrosceles, NCBI Reference Sequence: 
XM_023214147.2;  
Rhinopithecus bieti, NCBI Reference Sequence: XM_017868929.1; Colobus 
angolensis palliates, NCBI Reference Sequence: XM_011928483.1;  
Primate CD1e, 20 species 
Homo sapiens, NCBI Reference Sequence: NM_030893.4; Rhinopithecus 
roxellana, NCBI Reference Sequence: XM_030935233.1; Macaca nemestrina, 
NCBI Reference Sequence: XM_011769970.2; Macaca fascicularis, NCBI 
Reference Sequence: XM_015455159.1; Cercocebus atys, NCBI Reference 
Sequence: XM_012093256.1; Chlorocebus sabaeus, NCBI Reference 
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Sequence: XM_007976621.1; Theropithecus gelada, NCBI Reference 
Sequence: XM_025356228.1; Aotus nancymaae, NCBI Reference Sequence: 
XM_012449741.1; Pongo abelii, NCBI Reference Sequence: XM_003775532.3; 
Saimiri boliviensis boliviensis, NCBI Reference Sequence: XM_003937882.2; 
Cercocebus atys, NCBI Reference Sequence: XM_012093259.1; Gorilla gorilla 
gorilla, 
NCBI Reference Sequence: XM_004027025.3; Pan troglodytes, NCBI 
Reference Sequence: XM_513910.6; 
Pan paniscus, NCBI Reference Sequence: XM_003821003.4; Nomascus 
leucogenys, NCBI Reference Sequence: XM_003258652.4; Rhinopithecus 
bieti, NCBI Reference Sequence: XM_017868912.1; Piliocolobus tephrosceles, 
NCBI Reference Sequence: XM_023214159.1; Colobus angolensis palliatus, 
NCBI Reference Sequence: XM_011957140.1; Papio anubis, NCBI Reference 
Sequence: XM_021925303.2; Mandrillus leucophaeus, NCBI Reference 
Sequence: XM_011978335.1;  






Figure S12. Ancestral reconstruction by DataMonkey SLAC for CD1a 
surface- associated sites that contact TCR  
 
 
Figure S13. Genes in Mycobacterium tuberculosis involved in lipid 





Aleru, Omoshola, and Matthew F. Barber. “Battlefronts of Evolutionary 
Conflict between Bacteria and Animal Hosts.” PLoS Pathogens, vol. 16, 
no. 9, Sept. 2020. PubMed Central, doi:10.1371/journal.ppat.1008797.  
Adrian, Jonas, et al. “Adaptation to Host-Specific Bacterial Pathogens 
Drives Rapid Evolution of a Human Innate Immune Receptor.” Current 
Biology, vol. 29, no. 4, Feb. 2019, pp. 616-630.e5. ScienceDirect, 
doi:10.1016/j.cub.2019.01.058. 
Anisimov, Andrey P., Luther E. Lindler, and Gerald B. Pier. 2004. 
“Intraspecific Diversity of Yersinia Pestis.” Clinical Microbiology Reviews 
17(2): 434–64. 
Barber MF, Elde NC. 2014. Escape from bacterial iron piracy through 
rapid evolution of transferrin. Science 346(6215):1362–1366.  
Barral DC, Brenner MB. 2007. CD1 antigen presentation: how it works. 
Nat Rev Immunol. 7(12):929–941.  
Birkinshaw RW, Pellicci DG, Cheng T-Y, Keller AN, Sandoval-Romero M, 
Gras S, de Jong A, Uldrich AP, Moody DB, Godfrey DI, et al. 2015. Ab T 
cell antigen receptor recognition of CD1a presenting self lipid ligands. Nat 
Immunol. 16(3):258–266.  
Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP. 1995. Structure 
and function of the CD1 family of MHC-like cell surface proteins. 
Immunol Rev. 147(1):5–29.  
Bao, L., et al. “Mapping of Genes for the Human C5a Receptor (C5AR), 
Human FMLP Receptor (FPR), and Two FMLP Receptor Homologue 
Orphan Receptors (FPRH1, FPRH2) to Chromosome 19.” Genomics, vol. 
13, no. 2, June 1992, pp. 437–40. PubMed, doi:10.1016/0888-
7543(92)90265-t.  
Barber, Matthew F., and Nels C. Elde. “Escape from Bacterial Iron Piracy 
through Rapid Evolution of Transferrin.” Science (New York, N.Y.), vol. 





Brunette, Rebecca L., et al. “Extensive Evolutionary and Functional 
Diversity among Mammalian AIM2-like Receptors.” The Journal of 
Experimental Medicine, vol. 209, no. 11, Oct. 2012, pp. 1969–83. PubMed 
Central, doi:10.1084/jem.20121960.  
Bufe, Bernd, et al. “Recognition of Bacterial Signal Peptides by 
Mammalian Formyl Peptide Receptors: A NEW MECHANISM FOR 
SENSING PATHOGENS*.” Journal of Biological Chemistry, vol. 290, no. 
12, Mar. 2015, pp. 7369–87. ScienceDirect, doi:10.1074/jbc.M114.626747.  
Burge, C., and S. Karlin. “Prediction of Complete Gene Structures in 
Human Genomic DNA.” Journal of Molecular Biology, vol. 268, no. 1, Apr. 
1997, pp. 78–94. PubMed, doi:10.1006/jmbi.1997.0951.  
Cala-De Paepe D, Layre E, Giacometti G, Garcia-Alles LF, Mori L, Hanau 
D, de Libero G, de la Salle H, Puzo G, Gilleron M. 2012. Deciphering the 
role of CD1e protein in mycobacterial phosphatidyl-myo- inositol 
mannosides (PIM) processing for presentation by CD1b to T lymphocytes. 
J Biol Chem. 287(37):31494–31502.  
Castro CC, Luoma AM, Adams EJ. 2015. Coevolution of T-cell receptors 
with MHC and non-MHC ligands. Immunol Rev. 267(1):30–55.  
Chancellor A, Gadola SD, Mansour S. 2018. The versatility of the CD1 
lipid antigen presentation pathway. Immunology 154(2):196–203.  
Chandler CE, Harberts EM, Pelletier MR, Thaipisuttikul I, Jones JW, 
Hajjar AM, Sahl JW, Goodlett DR, Pride AC, Rasko DA, et al. 2020. Early 
evolutionary loss of the lipid A modifying enzyme PagP resulting in innate 
immune evasion in Yersinia pestis. Proc Natl Acad Sci USA. 
117(37):22984–22991. 
Choby JE, Buechi HB, Farrand AJ, Skaar EP, Barber MF. 2018. 
Molecular basis for the evolution of species-specific hemoglobin capture by 
Staphylococcus aureus. MBio 9(6) e01524–18. 
Caballero, Armando. Quantitative Genetics. Cambridge University Press, 
2020. Cooper, Max D., and Matthew N. Alder. “The Evolution of Adaptive 
Immune Systems.” Cell, vol. 124, no. 4, Feb. 2006, pp. 815–22. 
ScienceDirect, doi:10.1016/j.cell.2006.02.001.  
Crouser, Elliott D., et al. “Monocyte Activation by Necrotic Cells Is 
Promoted by Mitochondrial Proteins and Formyl Peptide Receptors.” 
Critical Care Medicine, vol. 37, no. 6, June 2009, pp. 2000–09. PubMed, 
doi:10.1097/CCM.0b013e3181a001ae.  
86 
Cussell, Peter J. G., et al. “The Formyl Peptide Receptor Agonist FPRa14 
Induces Differentiation of Neuro2a Mouse Neuroblastoma Cells into 
Multiple Distinct Morphologies Which Can Be Specifically Inhibited with 
FPR Antagonists and FPR Knockdown Using SiRNA.” PLoS ONE, vol. 14, 
no. 6, Public Library of Science, June 2019, pp. e0217815–e0217815. go-
gale- com.libproxy.uoregon.edu, doi:10.1371/journal.pone.0217815. 
Daugherty, Matthew D., and Harmit S. Malik. “Rules of Engagement: 
Molecular Insights from Host-Virus Arms Races.” Annual Review of 
Genetics, vol. 46, 2012, pp. 677–700. PubMed, doi:10.1146/annurev-genet-
110711-155522.  
Dietschi, Quentin, et al. “Evolution of Immune Chemoreceptors into 
Sensors of the Outside World.” Proceedings of the National Academy of 
Sciences, National Academy of Sciences, June 2017. www.pnas.org, 
doi:10.1073/pnas.1704009114.  
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